Dictyostelium Mutants

Phenotypes for Dictyostelium mutants

View other mutant types: All mutant strains - Null - Overexpression - Multiple - Other - Developmental

To view more details, including parent strains and references, click on the corresponding dictyBase ID.

Systematic Name	Strain Descriptor	Associated gene(s)	Phenotypes
DBS0235412	1C7	gp130	decreased cell-substrate adhesion \| delayed development \| increased growth rate
DBS0235413	24EH6	racE	abolished cytokinesis
DBS0235414	2F5	gp130	decreased cell-substrate adhesion \| delayed development \| increased growth rate
DBS0238601	5NT-	5NT	multiple tips in culminant \| delayed tip formation \| multiple tips in mound
DBS0235584	CF45-1-	cf45-1	increased aggregate size \| decreased cell motility \| increased cell-cell adhesion \| decreased aggregate size \| increased intracellular glucose level
DBS0235585	CF50-	cf50-1	increased aggregate size \| increased gene expression \| increased cell-cell adhesion \| decreased extracellular counting factor component(s) level \| increased protein level
DBS0235612	CMFR1-	cmfB	decreased gene expression \| abolished aggregation
DBS0235596	ChLim-	ChLim	increased growth rate \| increased phagocytosis
DBS0252637	DAip1-	aip1	decreased pinocytosis \| delayed cytokinesis \| decreased growth rate \| decreased phagocytosis
DBS0235659	DD3-3-	DD3-3	decreased gene expression \| precocious aggregation
DBS0236049	DDB_G0268012-	DDB_G0268012	wild type
DBS0236046	DDB_G0268158-	DDB_G0268158	wild type
DBS0236039	DDB_G0268678-	DDB_G0268678	wild type
DG1007	DDB_G0269232-	DDB_G0269232	abolished culmination
DBS0236025	DDB_G0270366-	DDB_G0270366	wild type
DBS0236026	DDB_G0270368-	DDB_G0270368	wild type
DBS0236036	DDB_G0270744-	DDB_G0270744	wild type
DBS0236043	DDB_G0276221-	DDB_G0276221	wild type
DBS0236042	DDB_G0276689-	DDB_G0276689	wild type
DBS0236041	DDB_G0277179-	DDB_G0277179	wild type
DBS0236045	DDB_G0277575-	DDB_G0277575	wild type
DBS0236044	DDB_G0278315-	DDB_G0278315	wild type
DBS0236038	DDB_G0279005-	DDB_G0279005	wild type
DBS0236032	DDB_G0279163-	DDB_G0279163	wild type
DBS0236033	DDB_G0279163-	DDB_G0279163	wild type
DBS0236028	DDB_G0279609-	DDB_G0279609	wild type
DBS0236029	DDB_G0279609-	DDB_G0279609	wild type
DBS0236035	DDB_G0280481-	DDB_G0280481	wild type
DBS0236019	DDB_G0281735-	DDB_G0281735	wild type
DBS0236020	DDB_G0281735-	DDB_G0281735	wild type
DBS0236027	DDB_G0290225-	DDB_G0290225	wild type
DG1003	DDB_G0291992-	DDB_G0291992	aberrant culminant morphology
DBS0236037	DDB_G0292186-	DDB_G0292186	wild type
DBS0236023	DDB_G0293116-	DDB_G0293116	wild type
DBS0236024	DDB_G0293116-	DDB_G0293116	wild type
DBS0236030	DDB_G0293762-	DDB_G0293762	wild type
DG1039	DG1039-	DDB_G0284037	aberrant fruiting body morphology
DG1040	DG1040-	DDB_G0276029	aberrant fruiting body morphology
DG1041	DG1041-	DDB_G0269126	aberrant fruiting body morphology
DG1054	DG1054-	DDB_G0277719	aberrant fruiting body morphology
DG1060	DG1060-	DDB_G0281953	aberrant fruiting body morphology
DG1062	DG1062-	DDB_G0286351	aberrant fruiting body morphology
DG1074	DG1074-	DDB_G0272108	aberrant fruiting body morphology
DG1080	DG1080-	DDB_G0281559	aberrant fruiting body morphology
DG1091	DG1091-	DG1091	decreased fruiting body size
DG1098	DG1098-	DG1098	decreased fruiting body size
DG1104	DG1104-	DDB_G0283535	abolished aggregation
DG1105	DG1105-	DG1105	abolished aggregation
DG1106	DG1106-	DG1106	abolished aggregation
DG1110	DG1110-	DDB_G0269128	aberrant fruiting body morphology
DG1112	DG1112-	DG1112	decreased stalk width
DG1113	DG1113-	DG1113	increased stalk length
DG1122	DG1122-	DG1122	aberrant fruiting body morphology
DG1124	DG1124-	DG1124	development arrests at loose aggregate stage
DG2033	DG2033-	DG2033	development arrests at mound stage
DG2044	DG2044-	DG2044	development arrests at loose aggregate stage
DBS0266700	Dd5P1-	Dd5P1	wild type
DBS0235660	Dd5P2-	Dd5P2	wild type \| increased basal F-actin level
DBS0266702	Dd5P3-	Dd5P3	wild type
DBS0266692	Dd5P4-	Dd5P4	decreased growth rate \| decreased phagocytosis \| decreased engulfment during phagocytosis \| multiple tips in mound
DBS0266693	Dd5P4-/ [act15]: Dd5P4	Dd5P4	wild type
DBS0266719	Dd5P4-/ [act15]: Dd5P4: GFP	Dd5P4	wild type
DBS0266695	Dd5P4-/ [act15]: GAP5P4	Dd5P4	decreased growth rate \| multiple tips in mound
DBS0266720	Dd5P4-/ [act15]: Hs-OCRL	Dd5P4	decreased phagocytosis
DBS0266721	Dd5P4-/ [act15]: Hs-OCRL(D422A)	Dd5P4	decreased phagocytosis
DBS0266694	Dd5P4-/ [act15]: cat5P4	Dd5P4	decreased growth rate \| multiple tips in mound
DBS0235940	EB1-	eb1	aberrant mitosis
DBS0236015	GEG04K11 (tmcB- in KAX3)	tmcB	small macrocysts \| increased number of peripheral cells during sexual reproduction \| aberrant aggregation during macrocyst formation
DBS0236016	GEG04V12 (tmcB- in V12)	tmcB	small macrocysts \| increased number of peripheral cells during sexual reproduction \| aberrant aggregation during macrocyst formation
DBS0236017	GEG10K23 (tmcC- in KAX3)	tmcC	increased number of peripheral cells during sexual reproduction \| aberrant aggregation during macrocyst formation
DBS0236018	GEG10V03 (tmcC- in V12)	tmcC	increased number of peripheral cells during sexual reproduction \| aberrant aggregation during macrocyst formation
DBS0302603	GFP: disgorgin/ disgorgin-	DDB_G0280955	wild type
DBS0302615	GFP: phgA(1-274: 283-438)/ phgA-	phgA	aberrant response to hypo-osmotic stress
DBS0302614	GFP: phgA/ phgA-	phgA	wild type
DBS0236085	GP138C-	cfrC	wild type
HTY506	HTY506	pkaR	aberrant spore morphology \| decreased spore viability \| decreased phosphorylation of actin \| increased sporulation \| precocious development \| aberrant fruiting body morphology
DBS0236716	PAKc-	pakC	decreased chemotaxis rate \| decreased lateral pseudopod suppression
DBS0236779	PIPkinA-	pik6	decreased gene expression \| abolished aggregation
DBS0236783	PKAcat-	pkaC	abolished aggregation
DBS0236840	R7	nosA	development arrests at mound stage
DBS0236900	RIP3	ripA	decreased cell polarity \| abolished activation of adenylate cyclase \| decreased chemotaxis rate \| abolished aggregation \| decreased myosin II assembly
DBS0236996	TL26	cotB	aberrant spore coat morphology
DBS0304456	[AS]alrA/ gcsA-	alrA \| gcsA	decreased growth rate in suspension \| cell cycle arrest
DBS0236827	[AS]proA/ proB-	proA \| proB	increased basal F-actin level \| abolished growth \| development arrests at slug stage \| aberrant cytokinesis \| decreased cell motility
DBS0238036	[AS]proA/ proB-/ [act15]: proA	proA \| proB	wild type
DBS0238037	[AS]proA/ proB-/ [act15]: proB	proA \| proB	wild type
DBS0302602	[OE]: disgorgin(Delta-Fbox)/ disgorgin-	DDB_G0280955	wild type
DBS0302601	[OE]: disgorgin(Q551A)/ disgorgin-	DDB_G0280955	aberrant contractile vacuole organization and biogenesis
DBS0302600	[OE]: disgorgin(R515A)/ disgorgin-	DDB_G0280955	aberrant contractile vacuole organization and biogenesis
DBS0302599	[OE]: disgorgin/ disgorgin-	DDB_G0280955	wild type
DBS0302610	[OE]: disgorgin/ phgA-	DDB_G0280955 \| phgA	aberrant contractile vacuole organization and biogenesis
DBS0302611	[OE]: phgA/ disgorgin-	DDB_G0280955 \| phgA	aberrant contractile vacuole organization and biogenesis
DBS0302656	[act15]: cnrN/ cnrN-	cnrN	wild type
DBS0302658	[act15]: cnrN/ smlA-	cnrN \| smlA	decreased fruiting body size
DBS0304457	[act15]: sodA/ gcsA-	gcsA \| sodA	wild type
DBS0304460	[act]: alrA/ gcsA-	alrA \| gcsA	wild type
HAD186	aarA-	aarA	aberrant tip formation \| aberrant establishment and/ or maintenance of cell polarity \| aberrant stalk formation \| aberrant Golgi localization \| aberrant centrosome localization \| decreased sporulation \| aberrant fruiting body morphology
DBS0266687	abiA-	abiA	decreased protein level \| aberrant cytokinesis \| decreased growth rate \| decreased chemotaxis to folate \| aberrant protein localization
DBS0266688	abiA-	abiA	aberrant protein localization
DBS0305672	abpB-	abpB	increased filopodium formation
DBS0236077	abpC-	abpC	aberrant thermotaxis \| aberrant phototaxis
DBS0237938	abpC-/ [act15]: GFP: abpC(9-148)	abpC	aberrant phototaxis
DBS0235426	abpC-/ [act15]: abpC	abpC	wild type
DBS0237945	abpC-/ [act15]: abpC(1-348: 449-857): GFP	abpC	aberrant F-actin organization \| aberrant phototaxis
DBS0237946	abpC-/ [act15]: abpC(1-556: 644-857): GFP	abpC	aberrant F-actin organization \| aberrant phototaxis
DBS0237941	abpC-/ [act15]: abpC(1-739): GFP	abpC	aberrant phototaxis
DBS0237949	abpC-/ [cotB]: abpC: GFP	abpC	aberrant phototaxis
DBS0237948	abpC-/ [ecmA]: abpC: GFP	abpC	wild type
DBS0235427	abpD-	abpD	decreased cell-cell adhesion \| decreased spore viability \| delayed development \| aberrant development
DBS0235428	abpE-	abpE-1 \| abpE-2	increased lateral pseudopod formation
DBS0349851	abpE-	abpE-1 \| abpE-2	increased phagocytosis
DBS0349852	abpE-/ [act15]: abpE	abpE-1 \| abpE-2	decreased phagocytosis
DBS0235562	acaA-	acaA	abolished aggregation \| decreased adenylate cyclase activity \| abolished cell polarity \| abolished streaming
GP6	acaA-	acaA	aberrant F-actin organization \| increased lateral pseudopod formation \| decreased chemotaxis rate \| aberrant cell morphology
DBS0306125	acapA-	acapA	wild type
DBS0306127	acapB-	acapB	wild type
TL177	acbA-	acbA	increased sensitivity to cisplatin \| abolished SDF production \| decreased spore viability \| abolished sorting to prestalk region
DBS0235440	acgA-	acgA	precocious spore germination
DBS0237788	acgA-	acgA	decreased gene expression \| decreased prespore cell differentiation
DBS0237790	acgA-/ [acrA]: lacZ	acgA \| acrA	mislocalized gene expression
DG1100	acrA-	acrA	decreased gene expression \| increased stalk length \| spores inviable \| decreased sporulation
DBS0237786	acrA-/ [act15]: acgA(1-401)	acgA \| acrA	decreased gene expression \| decreased prespore cell differentiation \| decreased sporulation
DBS0238203	adrm1-	adrm1-1	aberrant response to nutrients \| precocious gene expression \| precocious development
DBS0235457	ahhA-	ahhA	aberrant culminant morphology
DBS0266759	alp-	alp	wild type
DBS0235513	alrA-	alrA	increased aggregate size \| decreased intracellular glucose level \| decreased cell motility \| decreased extracellular counting factor component(s) level
DBS0235473	alrA-/ [act15]: alrA	alrA	wild type
DBS0235474	alxA-	alxA	development arrests at loose aggregate stage \| decreased growth rate \| aberrant fruiting body morphology
DBS0235475	alxA-	alxA	abolished sporulation \| decreased gene expression \| development arrests at mound stage \| aberrant fruiting body morphology
DBS0235488	alxA-/ [act15]: FLAG: alxA	alxA	delayed development
DBS0235476	alxA-/ [act15]: alxA(1-596): myc2	alxA	wild type
DBS0235477	alxA-/ [act15]: alxA(1-697): myc2	alxA	wild type
DBS0235478	alxA-/ [act15]: alxA(155-697): myc2	alxA	aberrant fruiting body morphology
DBS0235479	alxA-/ [act15]: alxA(293-697): myc2	alxA	aberrant fruiting body morphology
DBS0235480	alxA-/ [act15]: alxA(460-794): myc2	alxA	aberrant fruiting body morphology
DBS0235481	alxA-/ [act15]: alxA(D310A/ N311A)	alxA	wild type
DBS0235482	alxA-/ [act15]: alxA(Q181E/ Q183)	alxA	wild type
DBS0235483	alxA-/ [act15]: alxA(S700A/ S704A/ S708A)	alxA	wild type
DBS0235484	alxA-/ [act15]: alxA(S700D/ S704D/ S708D)	alxA	wild type
DBS0235485	alxA-/ [act15]: alxA(Y315D)	alxA	wild type
DBS0235486	alxA-/ [act15]: alxA(Y315F)	alxA	wild type
DBS0235487	alxA-/ [act15]: alxA: myc2	alxA	wild type
DBS0235489	alyA-	alyA	increased phagocytosis
DG1114	amdA-	amdA	decreased spore viability \| translucent sorus \| increased prestalk A cell differentiation
HM1158	amdA-	amdA	decreased fruiting body size \| decreased sporulation \| increased aspidocyte differentiation
DBS0235490	amiB-	amiB	abolished aggregation
DBS0235491	amiB-	amiB	decreased cAMP-induced cGMP pulse \| abolished down-regulation of growth phase genes \| decreased gene expression \| abolished aggregation \| decreased chemotaxis to cAMP \| decreased cAMP-induced cAMP pulse
DBS0235493	ampA-	ampA	delayed tip formation \| increased cell-cell adhesion \| increased cell-substrate adhesion \| mislocalized gene expression \| delayed development \| precocious gene expression \| decreased prestalk cell differentiation \| delayed gene expression
BS155	amtA-	amtA	decreased slug migration \| decreased aggregate size \| decreased fruiting body size \| increased growth rate
DBS0267100	amtA-	amtA	decreased spore viability \| decreased aggregate size \| increased number of aggregates \| decreased extracellular ammonia level \| increased intracellular glucose level \| decreased stalk length \| increased intracellular ammonia level
DBS0267101	amtA-/ [OE]: amtA	amtA	wild type
BS154	amtC-	amtC	decreased gene expression \| development arrests at slug stage \| mislocalized gene expression \| delayed culmination \| aberrant protein localization \| aberrant fruiting body morphology
DBS0235501	amtC-/ [act15]: cudA	amtC \| cudA	delayed culmination
DBS0235502	amtC-/ [ecmA]: cudA	amtC \| cudA	delayed culmination
DBS0235503	amtC-/ [pspA]: cudA	amtC \| cudA	development arrests at slug stage
DBS0235505	apm1-	apm1	aberrant contractile vacuole organization and biogenesis \| decreased spore germination \| aberrant response to hypo-osmotic stress \| decreased growth rate \| aberrant endosome morphology \| delayed development \| decreased stalk width
DBS0305085	apm2-/ [dscB]: GFP: vamp7A	apm2 \| vamp7A	increased localization of protein to the plasma membrane
DBS0235507	apm3-	apm3	decreased pinocytosis \| increased exocytosis \| aberrant post-lysosome organization and biogenesis \| aberrant endosome morphology
DBS0305083	apm3-/ [dscB]: GFP: vamp7A	apm3 \| vamp7A	increased localization of protein to the plasma membrane
DBS0235508	apm4-	apm4	wild type
DBS0235509	aprA-	aprA	increased aggregate size \| decreased spore viability \| aberrant cytokinesis \| increased growth rate \| aberrant fruiting body morphology \| decreased sporulation
DBS0235510	aprA-/ actin15: : aprA	aprA	decreased growth rate \| aberrant fruiting body morphology
DBS0238124	aqpA-	aqpA	decreased spore viability
DBS0235511	arkA-	arkA	increased gene expression \| aberrant fruiting body morphology
DBS0235514	aslA-	aslA-1 \| aslA-2	wild type
DBS0236305	atg1-	atg1	aberrant macroautophagy \| abolished autophagic vacuole formation
DBS0236304	atg1-	atg1	aberrant macroautophagy \| abolished autophagic vacuole formation
HR131	atg1-	atg1	abolished sporulation \| decreased growth rate in suspension \| abolished macroautophagy \| increased number of autophagosomes \| aberrant cellular response to nitrogen starvation \| abolished stalk cell differentiation \| abolished aggregation \| decreased growth rate on bacterial plates
DBS0238085	atg1-/ [act15]: atg1	atg1	wild type
DBS0238092	atg1-/ [act15]: atg1(1-628)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238087	atg1-/ [act15]: atg1(K36A)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238093	atg1-/ [act15]: atg1(P138S)	atg1	abolished aggregation
HR75	atg5-	atg5	aberrant macroautophagy \| abolished sporulation \| aberrant cellular response to nitrogen starvation \| multiple tips \| abolished aggregation
HR174	atg6-	atg6A	aberrant macroautophagy \| aberrant cellular response to nitrogen starvation \| multiple tips \| decreased fruiting body size \| decreased stalk length \| decreased sporulation
HR79	atg7-	atg7	aberrant macroautophagy \| abolished sporulation \| aberrant cellular response to nitrogen starvation \| multiple tips
HR141	atg8-	atg8	aberrant macroautophagy \| aberrant spore morphology \| increased sensitivity to cisplatin \| aberrant cellular response to nitrogen starvation \| multiple tips \| decreased fruiting body size \| decreased sporulation
DBS0305977	atg9-	atg9	increased stalk width \| aberrant sorus morphology \| decreased phagocytosis \| decreased growth rate \| aberrant slug migration \| aberrant fruiting body morphology \| aberrant slug formation \| multiple tips in mound
TL97	cadA-	cadA	multiple tips \| decreased sporulation \| delayed culmination \| increased prestalk cell differentiation
DBS0235568	car4-	carD	increased gene expression \| decreased gene expression \| aberrant fruiting body morphology
DBS0235570	carB-	carB	development arrests at mound stage
DBS0235573	carmil-	carmil	decreased pinocytosis \| decreased growth rate \| decreased basal F-actin level \| decreased aggregate size
IR40	catA-	catA	abolished catalase activity
IR41	catA-	catA	abolished catalase activity
IR29	catA-	catA	increased sensitivity to H2O2 (peroxide)
DBS0235574	catB-	catB	spores hypersensitive to H2O2 (peroxide) \| delayed development
DBS0304455	cblA-	cblA-1 \| cblA-2	abolished basal disc formation \| aberrant slug formation \| aberrant signal transduction
DBS0235575	cbpJ-	cbpJ	wild type
DBS0235661	cdk8-	cdk8	decreased gene expression \| mislocalized gene expression \| abolished aggregation
DBS0235578	cdk8-/ [cdk8]: cdk8	cdk8	wild type
DBS0306226	cenB-	cenB	abolished localization of protein to the microtubule organizing center \| increased number of centrosomes \| aberrant cell separation during cytokinesis \| aberrant nuclear envelope morphology \| aberrant nucleus morphology \| aberrant cytokinesis \| decreased microtubule nucleation \| aberrant centrosome organization
DBS0306227	cenB-/ [act15]: RFP: cenB	cenB	wild type
DBS0302444	cfaD-	cfaD	increased growth rate \| aberrant fruiting body morphology
DBS0302446	cfaD-/ [act15]: cfaD	cfaD	wild type
HO101	chcA-	chcA	decreased pinocytosis \| aberrant cytokinesis \| decreased growth rate
HO103	chcA-	chcA	abolished sporulation \| abolished cytokinesis \| abolished gene expression \| delayed aggregation \| abolished growth in suspension \| aberrant fruiting body morphology
DBS0235588	chcA-/ [act15]: GFP: mhcA	chcA \| mhcA	decreased positive regulation of GTPase activity
DBS0302455	chcA-/ [act15]: epnA: GFP	chcA \| epnA	aberrant localization of a protein to coated pits
DBS0235589	chcA-/ [cotB]: lacZ	chcA	mislocalized gene expression
DBS0235590	chcA-/ [ecmA]: lacZ	chcA	mislocalized gene expression
DBS0235591	chcA-/ [ecmB]: lacZ	chcA	mislocalized gene expression
DBS0235592	chcA-/ [pspA]: lacZ	chcA	mislocalized gene expression
DBS0235601	clc-	clc	abolished cytokinesis \| aberrant response to hypo-osmotic stress \| abolished growth \| aberrant fruiting body morphology
DBS0235604	clc-/ [act15]: GFP-clc(146-194)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphology
DBS0235605	clc-/ [act15]: GFP-clc(85-124)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphology
DBS0235607	clc-/ [act15]GFP: clc(1-124)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphology
DBS0235608	clmA-	clmA	aberrant response to hypo-osmotic stress
DBS0235613	cnrB-	cnrB	wild type
DBS0302655	cnrN-	cnrN	aberrant streaming \| increased cAMP-induced cAMP pulse \| increased F-actin polymerization \| increased number of aggregates
HG1770	cnxA-	cnxA	decreased extracellular Ca2+ uptake \| increased cytosolic Ca2+ response
DBS0235615	cofB-	cofB	wild type
DBS0235616	cofC-	cofC-1	wild type
DBS0235617	comB-	comB	abolished culmination
DG1016	comB-	comB	abolished culmination
DBS0235618	comC-	comC	aberrant streaming \| aberrant aggregation
DBS0235619	comD-	comD	abolished culmination
DBS0235620	comE-	comE	translucent sorus \| aberrant fruiting body morphology
DBS0235621	comF-	comF-1 \| comF-2	abolished aggregation
DBS0235622	comG-	comG	development arrests at mound stage \| multiple tips
DBS0235623	comH-	comH	development arrests at mound stage
HG1570	corA-	corA	aberrant cytokinesis \| decreased growth rate \| decreased cell motility \| aberrant cell morphology
HG1571	corA-	corA	aberrant cytokinesis \| decreased growth rate \| decreased cell motility \| aberrant cell morphology
HG1569	corA-	corA	aberrant cytokinesis \| decreased growth rate \| decreased cell motility \| aberrant cell morphology
DBS0305825	corB-	corB	aberrant phagocytosis \| decreased growth rate \| increased lateral pseudopod formation \| increased cell-substrate adhesion
TL55	cotA-	cotA	aberrant spore coat morphology
TL52	cotC-	cotC	aberrant spore coat morphology
DBS0238297	cpnA-	cpnA	delayed response to hypo-osmotic stress \| decreased culmination \| decreased growth rate \| aberrant cytokinesis \| delayed development \| aberrant fruiting body morphology
DBS0238320	cpnA-/ [act15]: GFP: cpnA	cpnA	delayed response to hypo-osmotic stress \| decreased culmination \| delayed development
DBS0235627	crlA-	crlA	increased aggregate size \| delayed tip formation \| decreased sorting to prestalk region \| increased growth rate
DBS0235628	crlA-/ [crlA]: crlA	crlA	increased aggregate size
DBS0235629	crlB-	crlB	wild type
DBS0235630	crlC-	crlC	wild type
HG1768	crtA-	crtA	decreased extracellular Ca2+ uptake \| increased cytosolic Ca2+ response
DBS0235633	crtf-	crtf	abolished sporulation \| decreased gene expression \| abolished aggregation
WTC127	cshA-	cshA	development arrests at loose aggregate stage \| decreased phagocytosis \| decreased growth rate \| delayed aggregation
DBS0235624	ctnA-	ctnA	decreased protein level \| increased cAMP-induced cGMP pulse \| increased aggregate size \| decreased basal F-actin level \| increased cell-cell adhesion \| increased GTP-gamma-S-stimulated guanylyl cyclase activity \| increased protein level \| increased cell motility \| increased intracellular glucose level \| decreased cAMP-induced cAMP pulse \| decreased myosin II assembly
DBS0235636	ctnB-	ctnB	decreased gene expression \| increased number of aggregates \| decreased fruiting body size
DBS0304927	ctnnA-	ctnnA	wild type
DG1071	ctr9-	ctr9	aberrant fruiting body morphology
DG1058	ctrA-	ctrA	decreased fruiting body size
DBS0235598	ctxA-	ctxA	aberrant cytokinesis \| aberrant cell morphology
HS1151	ctxA-	ctxA	aberrant cytokinesis \| decreased growth rate
DBS0237568	ctxA-/ [RNAi]enlA	ctxA \| enlA	wild type
DBS0237536	ctxA-/ [act15]: enlA(92-497)	ctxA \| enlA	wild type
DBS0235600	ctxB-	ctxB	aberrant cytokinesis \| aberrant cell morphology
DBS0235639	cudA-	cudA	abolished sporulation \| decreased gene expression \| development arrests at slug stage \| abolished stalk cell differentiation
DBS0235640	culA-	culA	multiple tips \| development arrests at tipped mound stage
DBS0235641	culA-/ [cotC]: culA	culA	increased sorus size \| decreased stalk length \| decreased sporulation
DBS0235642	culA-/ [ecmA]: culA	culA	increased sorus size \| decreased stalk length
DBS0235643	culA-/ [pkaC]pkaC	culA \| pkaC	wild type
DBS0266745	culB-	culB	decreased fruiting body size \| precocious gene expression \| aberrant slug formation \| decreased sporulation \| multiple tips in mound
DBS0266761	culB-/ [act15]: pkaC	culB \| pkaC	abolished gene expression \| abolished sporulation \| precocious gene expression \| abolished aggregation
DBS0235651	cybA-	cybA	abolished sporulation \| aberrant development
AK108	dagA-	dagA	abolished gene expression \| decreased gene expression \| abolished activation of adenylate cyclase \| abolished aggregation
DBS0235652	dagA-/ [act15]: dagA	dagA	wild type
DBS0235653	darA-	darA	decreased cell polarity \| decreased cell motility \| decreased aggregate size \| abolished aggregation
DBS0236307	dcsA-	dcsA	abolished cellulose biosynthesis
DG1099	dcsA-	dcsA	abolished sporulation \| aberrant spore coat morphology \| abolished cellulose biosynthesis \| abolished stalk formation \| abolished stalk cell differentiation
DG1128	dcsA-	dcsA	abolished sporulation \| aberrant spore coat morphology \| abolished cellulose biosynthesis \| abolished stalk formation
TL127	dcsA-	dcsA	abolished sporulation \| aberrant spore coat morphology \| abolished cellulose biosynthesis \| aberrant stalk formation \| abolished stalk formation \| abolished stalk cell differentiation
TL128	dcsA-/ [act15]: dcsA	dcsA	wild type
DBS0349804	detA-	detA	increased aggregate size \| decreased growth rate \| delayed development
DBS0349813	detA-/ [cotB]: GFP	detA	decreased prespore cell differentiation
DBS0349811	detA-/ [ecm0]: lacZ	detA	aberrant prestalk O cell differentiation
DBS0349812	detA-/ [ecmA0]: GFP	detA	increased prestalk cell differentiation
DBS0349808	detA-/ [ecmA0]: lacZ	detA	increased prestalk cell differentiation
DBS0349809	detA-/ [ecmA]: lacZ	detA	increased prestalk A cell differentiation
DBS0349810	detA-/ [ecmB]: lacZ	detA	delayed development
DBS0235695	dgkA-	dgkA	decreased spore viability \| increased myosin II assembly \| decreased chemotaxis rate \| aberrant development
AK299	dhkA-	dhkA	aberrant stalk morphogenesis \| increased sporulation in the presence of 8-Br-cAMP \| increased gene expression \| mislocalized gene expression \| decreased sporulation \| aberrant fruiting body morphology
DBS0235704	dhkB-	dhkB	precocious spore germination
TL135	dhkC-	dhkC	precocious culmination \| decreased spore germination \| precocious aggregation \| precocious development
DBS0235710	dhkK-	dhkK	aberrant slug migration \| delayed culmination \| delayed gene expression
DBS0235712	dhkK-/ [act15]: dhkK(D1125N)	dhkK	aberrant fruiting body morphology
DBS0348046	dhkM-	dhkM	abolished autophagic vacuole formation \| delayed development
DBS0348047	dhkM-	dhkM	abolished autophagic vacuole formation \| delayed development
DBS0235895	dimA-	dimA	thin fingers \| long fingers \| abolished prestalk cell differentiation \| increased slug size \| increased prespore cell differentiation \| decreased prestalk O cell differentiation \| aberrant fruiting body morphology
DBS0235901	dimB-	dimB	abolished response to DIF
DBS0235903	dimB-/ [act15]: dimA: GFP	dimA \| dimB	abolished localization of protein to the nucleus
DBS0235904	dimB-/ [act15]: dimB: GFP	dimB	wild type
DBS0235902	dimB-/ [cotB]: lacZ	dimB	increased prespore cell differentiation
DBS0235906	dimB-/ [ecmAO]: lacZ	dimB	decreased prestalk O cell differentiation
DBS0235907	dimB-/ [ecmO]: lacZ	dimB	aberrant prestalk cell differentiation
DBS0302608	disgorgin(1-571: 581-733)/ disgorgin-	DDB_G0280955	aberrant contractile vacuole organization and biogenesis \| aberrant cellular localization
DBS0302597	disgorgin-	DDB_G0280955	aberrant contractile vacuole organization and biogenesis \| aberrant response to hypo-osmotic stress
DBS0302607	disgorgin-/ [OE]: lvsA	DDB_G0280955 \| lvsA	aberrant contractile vacuole organization and biogenesis
DBS0302606	disgorgin-/ [OE]: lvsD	DDB_G0280955 \| lvsD	wild type
DBS0302678	disgorgin-/ [OE]: rab8A	DDB_G0280955 \| rab8A	aberrant contractile vacuole organization and biogenesis
DBS0302604	disgorgin-/ lvsA-	DDB_G0280955 \| lvsA	wild type
DBS0302605	disgorgin-/ lvsD-	DDB_G0280955 \| lvsD	aberrant contractile vacuole organization and biogenesis
DBS0304919	dlpA-	dlpA	aberrant cytokinesis
DBS0304920	dlpB-	dlpB	aberrant cytokinesis
DBS0304921	dlpC-	dlpC	aberrant cytokinesis
DBS0235913	dmpA-	dmpA	aberrant streaming \| translucent sorus \| delayed development \| decreased stalk cell differentiation \| decreased sporulation \| aberrant fruiting body morphology
HM1030	dmtA-	dmtA	thin fingers \| decreased outer basal disc size \| abolished prestalk O cell differentation \| abolished DIF production \| delayed tip formation \| decreased lower cup size \| delayed development \| decreased prestalk O cell differentiation \| aberrant fruiting body morphology \| decreased prestalk cell differentiation
DBS0235914	dnapkcs-	dnapkcs	increased sensitivity to DNA-damaging agents
DBS0266875	dnapkcs-/ GFP: pcna	dnapkcs \| pcna	aberrant response to DNA damaging agents
DBS0235915	dng1-	dng1	decreased growth rate \| delayed aggregation
DBS0235917	dnmA-	dnmA	decreased cytosine methylation in genomic DNA
DBS0235916	dnmA-	dnmA	aberrant culminant morphology \| translucent sorus \| decreased cytosine methylation in genomic DNA \| decreased sporulation
DG2015	docA-	docA	development arrests at mound stage
DBS0235920	dokA-	dokA	aberrant response to hyperosmotic stress \| translucent sorus \| decreased sporulation
DBS0349789	dotA-	dotA	decreased growth rate \| increased sensitivity to UV light \| decreased spore size \| delayed development \| abolished histone H3-K79 methylation
HAD172	dpoA-	dpoA	aberrant development
HAD200	dpoA-	dpoA	aberrant development
HAD201	dpoA-	dpoA	aberrant development
HAD202	dpoA-	dpoA	aberrant development
HAD203	dpoA-	dpoA	aberrant development
DBS0238474	drkC-	drkC	decreased phagocytosis \| decreased phagolysosome formation
DBS0238511	drkC-/ [act15]: drkC(1-497): YFP	drkC	decreased phagocytosis
DBS0238513	drkC-/ [act15]: drkC(K518R): YFP	drkC	decreased phagocytosis
DBS0238475	drkC-/ [act15]: drkC: YFP	drkC	wild type
DBS0235924	dscA-	dscA-1 \| dscA-2	aberrant cell morphology
DBS0235925	dstA-	dstA	abolished gene expression \| increased gene expression \| decreased gene expression \| delayed aggregation \| mislocalized gene expression \| decreased cell motility \| abolished stalk cell differentiation \| abolished sorting to prestalk region \| aberrant fruiting body morphology
DBS0235926	dstA-	dstA	delayed aggregation \| mislocalized gene expression \| decreased cell motility \| abolished stalk cell differentiation \| abolished sorting to prestalk region \| aberrant fruiting body morphology
DBS0238237	dstA-/ GFP: dstA(237-707): ORF+	dstA	abolished culmination \| decreased stalk length
DBS0238236	dstA-/ GFP: dstA(237-707): ORF+/ [OE]dutA(751-1322)	dstA \| dutA	decreased stalk length
DBS0252824	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 2C	2C \| dstA	aberrant fruiting body morphology
DBS0252823	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 7E	7E \| dstA \| hssB	wild type
DBS0252826	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0276165	DDB_G0276165 \| dstA	aberrant fruiting body morphology
DBS0252825	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0282325	DDB_G0282325 \| dstA	aberrant fruiting body morphology
DBS0252816	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssA	dstA \| hssA	wild type
DBS0235928	dstA-/ [act15]: dstA	dstA	wild type
DBS0235929	dstA-/ [cprB]: dstA	dstA	wild type
DBS0235930	dstA-/ [ecmAO]: dstA	dstA	wild type
DBS0235931	dstB-	dstB	decreased gene expression \| increased gene expression \| decreased growth rate
DBS0235933	dstB-/ [act15]: dstB	dstB	wild type
DBS0235934	dstB-/ [act15]: dstB(L1025R)	dstB	wild type
DBS0235935	dstB-/ [act15]: dstB(Y1143F)	dstB	wild type
DBS0235937	dtfA-	dtfA	delayed tip formation \| aberrant cytokinesis \| aberrant fruiting body morphology
DBS0238234	dutA-	dutA	wild type
DBS0235939	dwwA-	dwwA	aberrant cytokinesis \| aberrant F-actin organization \| aberrant cell morphology
DBS0347874	dymA-	dymA	decreased pinocytosis \| aberrant cell separation during cytokinesis \| decreased cell polarity \| aberrant mitochondrion morphology \| increased cell size \| increased basal disc size \| decreased growth rate \| aberrant stalk formation \| aberrant nucleus morphology \| aberrant endosome morphology \| delayed development \| aberrant pseudopod formation \| increased phagocytosis \| aberrant fruiting body morphology
DBS0349839	dymA-/ [dymA]: dymA	dymA	wild type
HJW117	ecmA-	ecmA	thin fingers \| weak slime trail \| long fingers
HJW01	ecmB-	ecmB	wild type
HJW03	ecmB-	ecmB	wild type
DBS0235944	ecmF-	ecmF	wild type
DBS0235946	egeB-	egeB	development arrests at mound stage
DBS0302590	elmoA-	elmoA	decreased culmination \| increased pseudopod formation \| increased localization of protein to the pseudopodium \| increased F-actin polymerization \| decreased cell motility \| delayed development \| abolished cell polarity \| increased phagocytosis
DBS0302591	elmoA-/ [act15]: elmoA: GFP	elmoA	wild type
DBS0302448	epnA-	epnA	aberrant spore morphology \| decreased spore viability \| aberrant cytokinesis \| abolished protein phosphorylation \| aberrant protein localization
DBS0302457	epnA-/ [act15]: GFP: epnA(253-677)	epnA	abolished localization of protein to the plasma membrane \| aberrant spore morphology \| abolished localization of protein to coated pits
DBS0302456	epnA-/ [act15]: epnA(1-133): GFP	epnA	aberrant localization of a protein to coated pits
DBS0302474	epnA-/ [act15]: epnA(R65A/ K78A): GFP	epnA	abolished localization of protein to the plasma membrane \| aberrant spore morphology \| abolished phosphatidylinositol-4,5-bisphosphate binding \| abolished localization of protein to coated pits
DBS0302475	epnA-/ [act15]: epnA(T107A): GFP	epnA	aberrant spore morphology
DBS0302454	epnA-/ [act15]: epnA: GFP	epnA	wild type
DBS0235947	eppA-	eppA	decreased growth rate \| delayed development \| decreased chemotaxis to folate \| decreased chemotaxis to cAMP \| decreased intracellular cAMP level
DBS0235948	eppA-/ [act6]: myc: eppA	eppA	wild type
HS174	erkB-	erkB	decreased cell motility \| abolished aggregation \| decreased chemotaxis to cAMP \| decreased cAMP-induced cAMP pulse \| decreased sporulation
AK240	erkB-	erkB	abolished aggregation \| decreased cAMP-induced cAMP pulse \| decreased sporulation
DBS0304864	expl7-	expl7	wild type
DBS0235951	fadA-	fadA	increased resistance to heat shock
DBS0235952	fadB-	fadB	wild type
DBS0236034	fam45-	fam45	wild type
DBS0236040	fam91-	fam91	wild type
DBS0235953	fbxA-	fbxA	decreased sporulation
DBS0235954	fbxA-/ [ecmA]: GFP(S65T)	fbxA	increased prespore cell differentiation
DBS0235956	fbxA1-	fbxA	development arrests at slug stage \| increased slug migration \| aberrant fruiting body morphology \| delayed culmination
DBS0235957	fbxA2-	fbxA	development arrests at slug stage \| increased slug migration \| aberrant fruiting body morphology \| delayed culmination
DBS0235958	fbxA3-	fbxA	development arrests at slug stage \| increased slug migration \| aberrant fruiting body morphology \| delayed culmination
DG1148	fcpA-	fcpA	aberrant fruiting body morphology
DBS0235960	fcsA-	fcsA	decreased fatty acid level
DBS0235961	fimA-	fimA	decreased cell size
HM1253	fncD2-	fncD2	increased sensitivity to cisplatin
HM1416	fncE-	fncE	increased sensitivity to cisplatin
HM1356	fncI-	fncI	increased sensitivity to cisplatin
HM1302	fncL-	fncL	increased sensitivity to cisplatin
HM1407	fncM-	fncM	increased sensitivity to cisplatin
DBS0235966	forA-	forA	wild type
DBS0235968	forB-	forB	wild type
DBS0235969	forC-	forC	aberrant culmination \| development arrests at tipped mound stage \| aberrant fruiting body morphology
DBS0304905	forC-/ [act15]: GFP-forC	forC	wild type
DBS0235970	forH-	forH	decreased cell-substrate adhesion \| decreased chemotaxis rate \| increased cell motility \| aberrant pseudopod formation \| aberrant cell morphology \| decreased filopodium formation
DBS0235971	forH-/ [act15]: GFP: forH	forH	increased filopodium formation \| decreased cell motility \| increased cell-substrate adhesion
DBS0302506	frmA-	frmA	delayed aggregation \| decreased cell motility \| increased cell-substrate adhesion \| decreased aggregate size \| aberrant cell morphology
DBS0304440	frmA-/ [unk]: GFP	frmA	decreased gene expression \| increased cell-cell adhesion \| delayed development \| aberrant development \| abolished phototaxis
DBS0302507	frmA-/ [unk]: frmA-HA	frmA	wild type
DBS0235976	fszA-	fszA	decreased number of mitochondria \| increased number of tubular mitochondria
DBS0235980	fszB-	fszB	decreased number of mitochondria \| increased number of tubular mitochondria \| decreased growth rate
DG1066	fut1-	fut1	aberrant fruiting body morphology
DBS0305025	gabT-	gabT	precocious development \| decreased sporulation
DBS0305026	gabT-[pkaC]: pkaC	gabT \| pkaC	aberrant protein secretion
DG1094	gacT-	gacT	aberrant fruiting body morphology
DBS0235989	gadA-	gadA	abolished SDF production \| decreased sporulation
TL198	gbfA-	gbfA	abolished gene expression \| development arrests at mound stage
DBS0305094	gbfA-	gbfA	abolished autophagic cell death \| abolished autophagic vacuole formation
DBS0235993	gbpB-	pdeE	aberrant chemotaxis to cAMP
DBS0235994	gbpC-	gbpC	decreased myosin light chain kinase activation \| decreased fruiting body size
DBS0235995	gbpC-	gbpC	decreased cell polarity \| aberrant myosin II organization \| decreased chemotaxis rate \| aberrant cell morphology \| decreased fruiting body size
DBS0302680	gbpC-	gbpC	decreased aggregate size \| abolished aggregation
DBS0304912	gbpC-/ [act15]: gbpC	gbpC	wild type
DBS0304917	gbpC-/ [act15]: gbpC(1-1698: 2005-2631)	gbpC	decreased chemotaxis to cAMP
DBS0304918	gbpC-/ [act15]: gbpC(311-2631)	gbpC	decreased chemotaxis to cAMP
DBS0304916	gbpC-/ [act15]: gbpC(F1892A)	gbpC	decreased chemotaxis to cAMP
DBS0304915	gbpC-/ [act15]: gbpC(F2082A/ E2084A/ F2564A/ E2566A)	gbpC	decreased chemotaxis to cAMP
DBS0304913	gbpC-/ [act15]: gbpC(K342N)	gbpC	decreased chemotaxis to cAMP
DBS0304914	gbpC-/ [act15]: gbpC(K905W)	gbpC	decreased chemotaxis to cAMP
DBS0235997	gbpD-	gbpD	decreased lateral pseudopod formation \| decreased cell-substrate adhesion \| increased cell polarity \| increased chemotaxis rate
DBS0235998	gbpD-/ [act15]: gbpD	gbpD	aberrant F-actin organization \| increased cell-substrate adhesion \| increased lateral pseudopod formation \| decreased chemotaxis rate \| abolished aggregation
DG1120	gbqA-	gbqA	aberrant fruiting body morphology
DBS0236002	gcsA-	gcsA	abolished gene expression \| development arrests at mound stage \| inviable \| cell cycle arrest \| spores inviable
DBS0236003	gcsA-/ [act15]: gcsA	gcsA	decreased spore viability \| development arrests at mound stage
DBS0236004	gdt1-	gdt1	decreased growth rate in suspension \| increased gene expression \| precocious aggregation
DBS0237190	gdt1-/ [act15]: pkaR(G135E/ G261A)	gdt1 \| pkaR	increased gene expression \| abolished aggregation
DBS0236006	gdt2-	gdt2	increased gene expression \| precocious aggregation
RI19	gefA-	gefA	decreased chemoattractant-mediated F-actin polymerization \| decreased cAMP-induced cGMP pulse \| decreased chemotaxis rate \| abolished activation of adenylate cyclase \| abolished aggregation \| decreased cAMP-induced cAMP pulse
JB10	gefA-	gefA	abolished aggregation
DBS0236009	gefB-	gefB	aberrant cytoskeleton organisation \| abolished pinocytosis \| increased basal F-actin level \| abolished growth \| delayed aggregation \| decreased phagocytosis \| decreased growth rate \| decreased aggregate size \| aberrant cell morphology \| aberrant fruiting body morphology
DBS0236868	gefC-	gefC	wild type
DBS0236869 (DBS0235543)	gefD-	gefD	wild type
DBS0236870	gefE-	gefE	aberrant thermotaxis \| aberrant phototaxis
DBS0236011	gefG-	gefG	wild type
DBS0236012	gefK-	gefK	wild type
DBS0236871	gefL-	gefL	aberrant thermotaxis \| aberrant phototaxis
HSB61	gefM-	gefM	increased cAMP-induced cGMP pulse \| aberrant activation of adenylate cyclase activity \| development arrests at mound stage \| decreased chemotaxis rate \| decreased lateral pseudopod suppression \| decreased cAMP-induced cAMP pulse
DBS0304968	gefQ-	gefQ	abolished Ras guanyl-nucleotide exchange factor activity \| increased myosin II assembly \| increased lateral pseudopod formation \| abolished sorting to prestalk region \| decreased fruiting body size \| abolished phototaxis \| multiple tips in mound
DBS0304985	gefQ-/ [act15]: GFP: gefQ(172-654)	gefQ	abolished Ras guanyl-nucleotide exchange factor activity \| decreased phototaxis
DBS0304986	gefQ-/ [act15]: GFP: gefQ(910-1298)	gefQ	decreased phototaxis
DBS0236014	gefR-	gefR	wild type
DG1109	ggtA-	ggtA	aberrant fruiting body morphology
DBS0266723	glcS-/ DH1	glcS	aberrant stalk morphogenesis \| decreased spore size \| decreased intracellular glycogen level \| decreased fruiting body size
DBS0266765	glcS-/ HMX	glcS	abolished cellulose biosynthesis \| decreased autophagic vacuole formation \| aberrant cell morphology
DBS0236078	glpD-	glpD	aberrant glycogen metabolism
DBS0236079	gmsA-	gmsA	decreased sexual fusion
DBS0236080	gmsA-	gmsA	decreased sexual fusion
DBS0238384	gnt14-	gnt14	wild type
DBS0238382	gnt15-	gnt15	decreased gene expression \| decreased growth rate \| increased calcium-independent cell-cell adhesion \| abolished aggregation \| abolished culmination
DBS0238383	gnt15-	gnt15	decreased gene expression \| decreased growth rate \| increased calcium-independent cell-cell adhesion \| abolished aggregation \| abolished culmination
DBS0238390	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0238391	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0236082	gol-	gol	increased resistance to cisplatin
DBS0236087	gpaA-	gpaA	increased stalk length \| decreased stalk width
JH131	gpaA-	gpaA	wild type
DBS0236091	gpaA-/ [ecmB]: lacZ	gpaA	decreased gene expression
DBS0236092	gpaA-/ [gpaA]: gpaA(G45V)	gpaA	delayed development
DBS0236093	gpaA-/ [gpaA]: gpaA(Q206L)	gpaA	increased basal disc size
DBS0236575	gpaB-	gpaB	decreased cAMP-induced cGMP pulse \| decreased cAMP-induced cAMP pulse
JH104	gpaB-	gpaB	decreased gene expression \| abolished activation of adenylate cyclase \| abolished aggregation
DBS0236096	gpaB-/ [act15]: gpaB	gpaB	abolished aggregation
DBS0266942	gpaB-/ [act15]: gpaB	gpaB	delayed aggregation
DBS0266939	gpaB-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB \| gpaD	abolished aggregation
DBS0237137	gpaB-/ [act15]: gpaB(D154V)	gpaB	aberrant aggregation \| decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased chemotaxis rate \| decreased cAMP-induced cAMP pulse
DBS0237138	gpaB-/ [act15]: gpaB(E190G)	gpaB	aberrant aggregation \| decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased cAMP-induced cAMP pulse
DBS0237139	gpaB-/ [act15]: gpaB(I104S)	gpaB	aberrant aggregation \| decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased chemotaxis rate \| decreased cAMP-induced cAMP pulse
DBS0237140	gpaB-/ [act15]: gpaB(L110S)	gpaB	aberrant aggregation \| decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased chemotaxis rate \| decreased cAMP-induced cAMP pulse
DBS0237141	gpaB-/ [act15]: gpaB(L76P)	gpaB	abolished aggregation
DBS0237142	gpaB-/ [act15]: gpaB(N74D)	gpaB	decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased chemotaxis rate \| abolished aggregation \| decreased cAMP-induced cAMP pulse
DBS0237143	gpaB-/ [act15]: gpaB(R64G)	gpaB	decreased chemotaxis rate \| abolished aggregation
DBS0237144	gpaB-/ [act15]: gpaB(S155P)	gpaB	decreased chemotaxis rate \| abolished aggregation
DBS0236097	gpaB-/ [gpaA]: gpaB	gpaB	abolished aggregation
DBS0236099	gpaB-/ [gpaB]: gpaB	gpaB	wild type
DBS0236098	gpaB-/ [gpaB]: gpaB(Q208L)	gpaB	aberrant protein localization
DBS0235986	gpaC-	gpaC	increased protein kinase A activity \| aberrant activation of adenylate cyclase activity \| decreased gene expression \| abolished aggregation
JH417	gpaD-	gpaD	decreased gene expression \| abolished SDF production \| decreased accumulation of cGMP \| decreased chemotaxis to folate \| aberrant fruiting body morphology \| decreased sporulation
DBS0266944	gpaD-/ [act15]: gpaB	gpaB \| gpaD	decreased accumulation of cGMP \| decreased chemotaxis to folate \| aberrant fruiting body morphology
DBS0266946	gpaD-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB \| gpaD	decreased accumulation of cGMP \| aberrant fruiting body morphology
DBS0266943	gpaD-/ [act15]: gpaD	gpaD	wild type
DBS0266945	gpaD-/ [act15]: gpaE	gpaD \| gpaE	decreased accumulation of cGMP \| decreased chemotaxis to folate \| aberrant fruiting body morphology
DBS0266947	gpaD-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD \| gpaE	decreased accumulation of cGMP \| decreased chemotaxis to folate \| aberrant fruiting body morphology
JH257	gpaE-	gpaE	delayed tip formation \| delayed gene expression
DBS0266941	gpaE-/ [act15]: gpaE	gpaE	precocious tip formation
DBS0266948	gpaE-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD \| gpaE	precocious tip formation
LW1	gpaG-	gpaG	wild type \| aberrant gamma-aminobutyric acid signaling pathway \| abolished SDF production
DBS0236107	gpaH-	gpaH	wild type
DBS0236108	gpaH-	gpaH	wild type
DBS0236109	gpaI-	gpaI	precocious aggregation \| decreased aggregate size \| increased number of aggregates \| decreased fruiting body size
LW5	gpbA-	gpbA	abolished aggregation
LW6	gpbA-	gpbA	decreased CRAC localization to the plasma membrane \| decreased positive regulation of Ras GTPase activity \| decreased cAMP-induced cGMP pulse \| decreased chemotaxis to folate \| decreased chemotaxis to cAMP \| decreased cAMP-induced cAMP pulse \| aberrant protein localization
DBS0304814	grlA-	grlA	decreased gene expression \| abolished SDF production \| decreased number of spores \| delayed gene expression \| delayed culmination
DBS0304815	grlA-/ [act15]: grlA: GFP	grlA	aberrant tip formation
DBS0236112	grlE-	grlE	abolished SDF production \| aberrant gamma-aminobutyric acid signaling pathway \| decreased sporulation
DBS0236113	grlE-	grlE	delayed aggregation \| aberrant gene expression \| decreased chemotaxis to cAMP
DBS0238865	grlJ-	grlJ	aberrant spore morphology \| decreased spore viability \| increased slug size \| precocious development \| decreased fruiting body size \| precocious gene expression
DBS0238866	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0238686	grpA-	grpA	decreased spore germination \| abolished protein secretion
DBS0238687	grpA-/ [act15]: grpA-FLAG	grpA	wild type
ARK200	gskA-	gskA	increased gene expression \| decreased gene expression \| decreased chemotaxis to cAMP \| abolished streaming \| decreased sporulation
DBS0236114	gskA-	gskA	decreased slug migration \| aberrant sorus morphology \| decreased stalk length
HM338	gskA-	gskA	precocious aggregation \| decreased prespore cell differentiation \| aberrant fruiting body morphology \| increased prestalk cell differentiation \| decreased sporulation
DBS0349800	gskA-/ [ecmA]: LacZ	gskA	aberrant gene expression
DBS0349801	gskA-/ [ecmB]: LacZ	gskA	aberrant gene expression
DBS0266891	gtaC-	gtaC	abolished stalk cell differentiation in vitro \| aberrant streaming \| decreased aggregate size \| aberrant prestalk B cell differentiation
DBS0236120	gxcA-	gxcA	decreased chemoattractant-mediated F-actin polymerization \| delayed development \| decreased positive regulation of Rac GTPase activity
DBS0236121	gxcB-	gxcB	decreased exocytosis \| aberrant cytoskeleton organisation \| delayed development
DBS0238825	gxcDD-	gxcDD	aberrant streaming \| delayed development
DBS0236129	hbx2-	hbx2	wild type
DBS0236130	hbx2-	hbx2	wild type
DBS0236153	hcpA-	hcpA	decreased growth rate in suspension at low temperature
DBS0236157	hcpB-	hcpB	wild type
DBS0305109	hdaB-	hdaB	decreased sporulation \| decreased histone deacetylase activity
HM1012	helC-	helC	decreased gene expression \| delayed development \| aberrant fruiting body morphology
HM444	helC-	helC	decreased gene expression \| delayed development \| aberrant fruiting body morphology
DG1059	helE-	helE	increased slug migration
DBS0236163	helF-	helF	increased stalk cell differentiation \| increased slug size \| delayed development \| increased gene silencing by RNA interference
DBS0238583	hipA-	hipA	aberrant spore morphology \| decreased spore viability \| aberrant spore coat morphology
DBS0252818	hssA-	hssA	wild type
DBS0349776	htt-	htt	decreased growth rate in suspension \| aberrant cell separation during cytokinesis \| decreased chemotaxis rate \| delayed development \| delayed gene expression \| decreased myosin II assembly
DBS0349788	htt-	htt	aberrant aggregation \| development arrests at loose aggregate stage \| aberrant spore morphology \| decreased spore viability \| aberrant response to hypo-osmotic stress \| aberrant F-actin organization \| decreased number of spores \| aberrant response to starvation \| abolished streaming \| aberrant development \| multiple tips in mound \| aberrant prespore cell differentiation \| abolished calcium-independent cell-cell adhesion
DBS0349794	ibrA-	ibrA	aberrant stalk formation
DBS0252699	icmA-	icmA-1 \| icmA-2	abolished sporulation \| aberrant signal transduction during aggregation \| abolished growth \| development arrests at mound stage \| abolished cell polarity \| abolished streaming \| aberrant cAMP wave formation \| delayed gene expression \| aberrant fruiting body morphology \| aberrant protein localization
DBS0252702	icmA-/ [act15]: TAP: YFP: rasG	icmA-1 \| icmA-2 \| rasG	abolished C-terminal protein amino acid methylation
DBS0252701	icmA-/ [act15]: hICMT	icmA-1 \| icmA-2	wild type
DBS0252700	icmA-/ [act15]: icmA	icmA-1 \| icmA-2	wild type
DBS0236421	icpA-	icpA	aberrant mitosis \| aberrant cytokinesis \| aberrant protein localization
DBS0238521	icpA-/ [act15]: GFP: icpA(1-1013)	icpA	aberrant protein localization
BS153	ifkA-	ifkA	increased aggregate size \| precocious aggregation \| decreased extracellular counting factor component(s) level \| precocious gene expression
BS160	ifkB-	ifkB	increased gene expression
DBS0236425	ino1-	ino1	decreased intracellular myo-inositol level \| abolished growth \| decreased phagocytosis \| increased intracellular 2,3-bisphosphoglycerate level \| multiple tips in mound
DBS0266326	iplA-	iplA	abolished cellulose biosynthesis \| abolished autophagic vacuole formation \| abolished autophagic cell death
HM1038	iplA-	iplA	abolished cAMP-induced Ca2+ influx \| precocious aggregation \| delayed aggregation \| increased chemotaxis to arachidonic acid
DBS0252878	iptA-	iptA	decreased spore viability
DBS0236031	kctd9-	kctd9	wild type
DBS0236489	kif12-	kif12	aberrant myosin II organization \| aberrant cytokinesis \| aberrant protein localization
DBS0236490	kif12-/ [act15]: FLAG: kif12	kif12	wild type
DBS0302534	kif13-	kif13	decreased spindle stabilization \| precocious spindle elongation
DBS0236494	kif7-	kif7	aberrant cell motility
DBS0236491	kil1-	kil1	abolished resistance to pathogenic bacteria
DBS0236492	krsA-	krsA	decreased chemotaxis to cAMP
DBS0238720	krsA-	krsA	aberrant response to hyperosmotic stress \| precocious culmination \| abolished activation of adenylate cyclase \| decreased aggregate size \| decreased intracellular cAMP level \| precocious gene expression \| abolished streaming \| decreased cell size
DBS0236493	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238721	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238722	krsA-/ [act15]: GFP: krsA(K49R)	krsA	aberrant streaming
DBS0238723	krsA-/ [act15]: GFP: krsA(T173A)	krsA	abolished streaming
DBS0238725	krsA-/ [act15]: GFP: krsA(deltaC)	krsA	aberrant streaming
DBS0238724	krsA-/ [act15]: GFP: krsA(deltaKinase)	krsA	abolished streaming
DBS0238726	krsA-/ [act15]: GFP: krsA(deltaNS)	krsA	abolished streaming
DBS0236495	ku80-	ku80	increased sensitivity to DNA-damaging agents
AK127	lagC-	tgrC1	development arrests at loose aggregate stage \| aberrant aggregation \| increased aggregate size
DBS0236498	lagD-	tgrD1	aberrant aggregation \| aberrant cAMP signaling during aggregation \| abolished streaming
DBS0236499	limB-	limB	decreased cell polarity \| decreased cell-substrate adhesion \| decreased gene expression \| development arrests at mound stage \| aberrant F-actin organization \| aberrant cell-cell adhesion \| decreased chemotaxis rate \| abolished sorting to prestalk region \| delayed gene expression
DBS0236502	limB-/ [act15]: paxB: GFP	limB \| paxB	development arrests at mound stage
DBS0236500	limB-/ [cotC]: limB	limB	development arrests at mound stage
DBS0236501	limB-/ [ecmAO]: limB	limB	wild type
DBS0236503	limE-	limE	aberrant cytokinesis
DBS0236506	limF-	limF	decreased phagocytosis
DBS0236511	lipA-	lipA	wild type
DBS0236512	lipA-	lipA	wild type
DG1006	lipA-	lipA	abolished culmination
DG1056	lipB-	captC	aberrant fruiting body morphology
DBS0236516	lrrA-	lrrA	decreased cell polarity \| increased aggregate size \| decreased cell-substrate adhesion \| increased basal F-actin level \| decreased spore viability \| abolished chemotaxis \| decreased gene expression \| development arrests at mound stage \| abolished aggregation \| aberrant cell morphology \| delayed gene expression
DBS0236517	lst8-	lst8	decreased F-actin polymerization \| aberrant activation of adenylate cyclase activity \| decreased chemotaxis rate \| abolished aggregation \| decreased myosin II assembly
AD60	lvsA-	lvsA	aberrant contractile vacuole organization and biogenesis \| abolished cytokinesis \| decreased pinocytosis \| aberrant response to hypo-osmotic stress \| decreased phagocytosis \| increased cell-substrate adhesion
AD63	lvsA-	lvsA	abolished cytokinesis \| abolished cAMP-induced Ca2+ influx
DBS0236521	lvsB-	lvsB	increased secretion of lysosomal enzyme \| increased lysosome size \| increased exocytosis \| aberrant post-lysosome organization and biogenesis \| increased pinocytosis
DBS0236522	lvsC-	lvsC	wild type
DBS0236523	lvsD-	lvsD	wild type
DBS0236524	lvsE-	lvsE	wild type
DBS0236525	lvsF-	lvsF	wild type
DBS0236536	malA-	malA	wild type
DBS0236543	mekA-	mekA	decreased aggregate size \| precocious development
DBS0266843	mgp1-	mgp1	aberrant contractile vacuole organization and biogenesis \| increased phototaxis \| increased filopodium formation \| decreased cell motility \| decreased fruiting body size \| abolished streaming \| decreased stalk width \| decreased stalk length
DBS0266846	mgp1-/ mgp2-	mgp1 \| mgp2	aberrant contractile vacuole organization and biogenesis \| increased filopodium formation \| aberrant culmination \| decreased cell motility \| decreased phototaxis \| decreased stalk length
DBS0266844	mgp2-	mgp2	increased aggregate size \| increased slug size
HS1	mhcA-	mhcA	aberrant protein localization
HS2207	mhcA-	mhcA	abolished cytokinesis \| development arrests at mound stage
HS2206	mhcA-	mhcA	abolished bleb formation
HK323	mhcA-	mhcA	decreased cell motility
DBS0266674	mhcA-/ [act15]: GFP: abpC(9-148)	abpC \| mhcA	decreased uropod retraction \| decreased pseudopod retraction
DBS0237564	mhcA-/ [act15]: GFP: ctxA/ [RNAi]enlA	ctxA \| enlA \| mhcA	aberrant cytokinesis, contractile ring contraction
DBS0266675	mhcA-/ [act15]: GFP: mhcA(E476K)	mhcA	decreased pseudopod retraction
DBS0236548	mhcA-/ [act15]: GFP: pats1(2087-2351)	mhcA \| pats1	aberrant cytokinesis
DBS0236549	mhcA-/ [act15]: limE(1-145): GFP	limE \| mhcA	increased F-actin polymerization
DBS0238158	mhcA-/ [act15]: mhcA(81-2116)	mhcA	decreased growth rate \| development arrests at tipped mound stage
CW0401	mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A)	mhcA	decreased growth rate in suspension \| increased myosin II assembly
DBS0236550	mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A)	mhcA	decreased filopodium formation
DBS0236551	mhcA-/ [act15]: mhcA(T1823D/ T1833D/ T2029D)	mhcA	increased filopodium formation
DBS0238399	mhcA-/ [act15]: rapA(G12V)	mhcA \| rapA	increased basal F-actin level \| aberrant myosin II organization \| increased cell polarity
DBS0236552	mhcA-/ [mhcA]: mhcA(1-1224)	mhcA	aberrant cytokinesis \| development arrests at mound stage
DBS0238157	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R689H)	mhcA	decreased actin filament sliding
DBS0236547	mhcA-/ [unk]: GFP: icpA	icpA \| mhcA	aberrant protein localization
CW0371	mhkA-	mhkA	increased myosin II assembly
DBS0236557	mhkA-/ [act15]: mhkA	mhkA	decreased growth rate in suspension \| development arrests at mound stage \| aberrant cytokinesis \| decreased myosin II assembly
CW0166	mhkB-	mhkB	increased myosin II assembly
CW0403	mhkC-	mhkC	increased myosin II assembly \| aberrant cytokinesis
DG1069	mhkC-	mhkC	aberrant fruiting body morphology
CW0435	mhkD-	mhkD	increased myosin II assembly
DBS0236559	midA-	midA	decreased growth rate in suspension \| aberrant spore morphology \| decreased thermotaxis \| increased intracellular glutamate level \| decreased intracellular glycogen level \| increased extracellular ammonia level \| increased slug migration \| decreased growth rate on bacterial plates \| decreased cell size \| decreased phototaxis
DG1020	migA-	migA	abolished slug migration \| decreased fruiting body size \| aberrant fruiting body morphology
DBS0266620	mipp1-	mipp1	aberrant inositol phosphate metabolic process \| increased response to lithium
DBS0236560	mkcA-	mkcA	decreased gene expression
DG1101	mkcB-	mkcB	decreased fruiting body size
DBS0236564	mkkA-	mkkA	precocious culmination \| decreased sorus size \| increased stalk length
DG1121	mkpA-	mkpA	abolished aggregation
DBS0236566	mlcE-	mlcE	decreased growth rate in suspension \| aberrant cytokinesis \| delayed aggregation \| decreased cell motility \| mislocalized gene expression \| aberrant development
DBS0238058	mlcE-/ [act15]: myc: mlcE	mlcE	wild type
DBS0236567	mlcR-	mlcR	aberrant myosin II organization \| aberrant cytokinesis \| development arrests at mound stage
HS183	mlkA-	mlkA	aberrant cytokinesis
DG1033	modA-	modA	aberrant fruiting body morphology
DBS0266903	mpl1-	mpl1	decreased cell motility \| decreased chemotaxis to cAMP \| abolished streaming \| abolished aggregation
DBS0266904	mpl1-/ [act15]: flag: mpl1	mpl1	wild type
DBS0236569	mrps4-	mrps4	delayed aggregation \| aberrant fruiting body morphology
HM1463	mus81-	mus81	wild type
DBS0236570	mybB-	mybB	decreased cAMP-induced cGMP pulse \| decreased gene expression \| decreased activation of adenylate cyclase \| abolished aggregation \| decreased cAMP-induced cAMP pulse
DBS0236571	mybB-	mybB	abolished aggregation
HM388	mybC-	mybC	decreased SDF production \| decreased gene expression \| abolished culmination
DBS0236572	mybE-	mybE	increased slug size \| abolished outer basal disc formation
DBS0237709	mybE-/ [mrrA]: lacZ	mrrA \| mybE	aberrant prestalk cell differentiation
DBS0236573	mybE-/ mybE: GFP	mybE	wild type \| aberrant prestalk cell differentiation
HDT1	myoA-	myoA	delayed aggregation \| decreased cell motility \| decreased chemotaxis rate \| decreased lateral pseudopod suppression
HDT2	myoA-	myoA	increased secretion of lysosomal enzyme
DBS0236579	myoB-	myoB	increased secretion of lysosomal enzyme
DBS0236580	myoB-	myoB	decreased phagocytosis \| delayed aggregation \| decreased cell motility \| decreased lateral pseudopod suppression
DBS0236583	myoB-/ [AS]myoD	myoB \| myoD	decreased pinocytosis \| aberrant aggregation \| decreased growth rate \| decreased phagocytosis \| decreased cell motility \| decreased aggregate size
DBS0236584	myoB-/ [AS]myoD/ [KD]myoC	myoB \| myoC \| myoD	small pinosomes \| decreased pinocytosis \| aberrant aggregation \| decreased growth rate \| decreased phagocytosis \| decreased cell motility \| increased number of pinosomes \| decreased aggregate size
DBS0236585	myoC-	myoC	decreased phagocytosis
DBS0236587	myoD-	myoD	wild type
HDT8	myoF-	myoF	wild type
DBS0236589	myoI-	myoI	decreased spore germination
DBS0236592	myoI-	myoI	decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased phagocytosis \| aberrant cell morphology
HDT15	myoI-	myoI	decreased phagocytosis
HDT17	myoI-	myoI	decreased cell-cell adhesion \| decreased protein level \| decreased cell-substrate adhesion \| decreased phagocytosis \| decreased filopodium formation
DBS0266889	myoI-/ [act15]: GFP: myoI	myoI	wild type
DBS0266890	myoI-/ [act15]: GFP: myoI(809-1154)	myoI	decreased phagocytosis
DBS0237617	myoI-/ [act15]: gbpD	gbpD \| myoI	increased pseudopod formation \| increased cell-substrate adhesion \| aberrant cell morphology
HTD7	myoJ-	myoJ	wild type
DBS0349844	myoK-	myoK	aberrant cortical actin cytoskeleton stabilization \| delayed aggregation \| decreased phagocytosis \| aberrant engulfment during phagocytosis \| decreased chemotaxis rate \| aberrant cell morphology
DBS0349846	myoK-/ [act15]: YFP: myoK(1-121: 262-858)	myoK	decreased phagocytosis
DBS0349850	myoK-/ [act15]: myoK	myoK	increased phagocytosis
DBS0349854	myoK-/ [act15]: pakB(1-337: 563-852)	myoK \| pakB	wild type
DBS0236595	myoM-	myoM	wild type
SB12	napA-	napA	decreased cell-cell adhesion \| decreased cell polarity \| decreased cell-substrate adhesion \| decreased cell motility \| decreased basal F-actin level \| decreased cell size \| decreased phototaxis
HC476	ncsA-	ncsA	increased intracellular cAMP level \| precocious gene expression \| precocious development
HC477	ncsA-	ncsA	increased intracellular cAMP level \| precocious gene expression \| precocious development
DBS0304633	nfaA-	nfaA	aberrant localization of protein to the plasma membrane \| increased pseudopod formation \| increased chemoattractant-mediated F-actin polymerization \| increased basal F-actin level \| delayed aggregation \| decreased cell motility \| aberrant cAMP signaling during aggregation \| aberrant regulation of Ras GTPase activity \| aberrant regulation of protein kinase activity \| decreased chemotaxis to cAMP
DBS0236604	nhe1-	nhe1	decreased intracellular pH level \| decreased cell polarity \| aberrant F-actin organization \| decreased chemotaxis rate
DBS0349841	nhe1-/ [act15]: mhcA: GFP	mhcA \| nhe1	aberrant protein localization
DBS0236605	nhe1-/ [act15]: nhe1: HA	nhe1	wild type
DBS0236606	nosA null (15-S-12)	nosA	development arrests at mound stage
DBS0236607	nosA null (2E4)	nosA	development arrests at mound stage
DBS0235950	nosA-	nosA	development arrests at mound stage
DBS0236608	noxA-	noxA	abolished sporulation \| aberrant development
DBS0236611	noxA-/ [act15]: noxA: myc2	noxA	aberrant fruiting body morphology
DBS0236612	noxB-	noxB	abolished sporulation \| decreased superoxide production \| aberrant development
DBS0236613	noxC-	noxC	abolished sporulation \| aberrant development
DBS0238849	npcA-	npcA	wild type
DBS0236695	nramp1-	nramp1	increased infection rate by Mycobacterium avium \| increased infection rate by Legionella pneumophila \| abolished iron ion transport
DBS0236696	nramp1-/ [act15]: nramp1: GFP	nramp1	decreased infection rate by Legionella pneumophila
DBS0236697	nramp1-/ [act15]: nramp1: GFP	nramp1	decreased infection rate by Legionella pneumophila
DBS0236955	nxnA-	nxnA	decreased culmination \| decreased growth rate \| delayed development \| decreased chemotaxis to cAMP \| decreased lysosomal enzyme activity
DBS0236702	nxnA-/ [act15]: GFP: nxnB	nxnA \| nxnB	development arrests at mound stage
DBS0236704	osbA-	osbA	increased slug migration \| precocious development
DBS0238357	p2xA-	p2xA	aberrant response to hypo-osmotic stress
DBS0304487	p2xA-	p2xA	wild type
DBS0238362	p2xA-/ [act15]: p2xA: GFP	p2xA	wild type
DBS0306166	p2xB-	p2xB	wild type
DBS0306167	p2xC-	p2xC	wild type
DBS0306168	p2xD-	p2xD	wild type
DBS0304486	p2xE-	p2xE	wild type
DBS0236705	pakA-	pakA	aberrant cytokinesis \| delayed development
DBS0236706	pakA-	pakA	wild type
DBS0236707	pakA-/ [act15]: pakA	pakA	wild type
DBS0236709	pakB-	pakB	decreased growth rate
DBS0236712	pakB-/ [act15]: GFP-pak(1-600)	pakB	abolished cytokinesis
DBS0236710	pakB-/ [act15]: GFP-pakB(1-337: 563-851)	pakB	abolished cytokinesis \| increased pinocytosis \| increased phagocytosis
HC392	patB-	patB	abolished growth on bacterial plates \| abolished growth in acidic medium
DBS0236726	pats1-	pats1	aberrant cytokinesis
DBS0236727	pats1-/ [act15]: GFP: pats1(2087-2351)	pats1	aberrant cytokinesis
DBS0236728	paxB-	paxB	decreased cell-substrate adhesion \| decreased gene expression \| abolished slug migration \| development arrests at mound stage \| decreased sorting to prestalk region \| aberrant fruiting body morphology
DBS0304926	paxB-	paxB	aberrant cell separation during cytokinesis \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased cell motility
DBS0304930	paxB-/ [act15]: GFP: paxB	paxB	wild type
DBS0236730	paxB-/ [ecmA]: paxB: GFP	paxB	decreased sorting to prestalk region
DBS0236732	paxB-/ [pspA]: paxB: GFP	paxB	decreased sorting to prestalk region
DBS0236733	pcp-	pcp	wild type
DBS0236734	pde4-	pde4	decreased culmination \| delayed slug formation \| delayed culmination
DBS0236735	pde4-/ [act15]: pde4: GFP	pde4	wild type
DBS0236736	pdeD-	pdeD	decreased cAMP-induced Ca2+ influx \| delayed cAMP-induced Ca2+ influx \| decreased Ca2+-induced Ca2+ influx
UK7	pdsA-	pdsA	decreased 3',5'-cyclic-AMP phosphodiesterase activity \| abolished aggregation
DBS0236741	pefA-	pefA	wild type
DBS0236744	pefB-	pefB	wild type
HW260	pgtA-	pgtA	increased cell size
DBS0236752	phdA-	phdA	decreased basal F-actin level \| decreased aggregate size \| decreased chemotaxis rate \| decreased fruiting body size
DBS0236753	phdA-/ [act15]: phdA	phdA	wild type
DBS0236754	phdA-/ [act15]: phdA: GFP	phdA	wild type
DBS0304869	phg1A-/ [act15]: phg1a(1-276): phg1b(221-587)	phg1a \| phg1b	decreased phagocytosis
DBS0304868	phg1A-/ [act15]: phg1b	phg1a \| phg1b	increased secretion of lysosomal enzyme \| decreased cell-substrate adhesion \| decreased phagocytosis
DBS0304870	phg1A-/ [act15]: phg1b(1-220): phg1a(277-642)	phg1a \| phg1b	decreased phagocytosis
DBS0236755	phg1a-	phg1a	increased secretion of lysosomal enzyme \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased phagocytosis \| abolished resistance to pathogenic bacteria \| decreased growth rate \| development arrests at slug stage
DBS0236757	phg1a-/ [act15]: kil1	kil1 \| phg1a	wild type
DBS0304866	phg1b-	phg1b	increased secretion of lysosomal enzyme \| decreased phagocytosis \| decreased growth rate \| abolished culmination
DBS0236758	phg2-	phg2	decreased cell-substrate adhesion \| decreased phagocytosis \| aberrant cytokinesis \| aberrant F-actin organization \| decreased cell motility \| aberrant response to nutrients \| aberrant cell morphology \| precocious development \| precocious gene expression
DBS0238400	phg2-	phg2	increased filopodium formation \| increased basal F-actin level \| increased cell-substrate adhesion \| decreased chemotaxis to cAMP \| aberrant cell morphology \| increased phagocytosis
DBS0236760	phg2-/ [act15]: GFP: phg2(199-1389)	phg2	decreased phagocytosis
DBS0237615	phg2-/ [act15]: gbpD	gbpD \| phg2	increased pseudopod formation \| aberrant cell morphology \| abolished chemotaxis to cAMP
HG1648	phgA-	phgA	aberrant contractile vacuole organization and biogenesis \| aberrant response to hypo-osmotic stress
DBS0236761	phgA-/ [act6]: GFP: lvsA	lvsA \| phgA	aberrant protein localization
DBS0236762	phlp1-	phlp1	decreased growth rate in suspension \| decreased cAMP-induced cGMP pulse \| aberrant regulation of protein modification \| abolished chemotaxis \| abolished aggregation \| decreased growth rate on bacterial plates \| decreased cAMP-induced cAMP pulse \| aberrant protein localization
DBS0236763	phlp1-/ [OE]: phpl1	phlp1	wild type
DBS0236764	phlp3-	phlp3	wild type
HW288	phyA-	phyA	abolished sporulation \| decreased peptidyl-proline hydroxylation \| abolished stalk formation \| abolished culmination
DBS0266771	phyA-/ [ecmA]: phyA(D132N): myc	phyA	decreased peptidyl-proline hydroxylation
DBS0266770	phyA-/ [ecmA]: phyA(R276A): myc	phyA	abolished peptidyl-proline hydroxylation \| abolished culmination
DBS0236767	pia-	piaA	aberrant activation of adenylate cyclase activity
DBS0236770	piaA-	piaA	aberrant cytokinesis
DBS0236771	piaA-	piaA	abolished aggregation \| decreased myosin II assembly
DBS0304637	piaA-	piaA	decreased cell polarity \| decreased cell motility \| decreased chemotaxis rate \| aberrant protein tyrosine phosphorylation
DBS0236772	pikA-	pikA	wild type
DBS0236774	pikB-	pikB	wild type
DBS0236776	pikC-	pikC	wild type
DBS0236777	pikD¹	pikD	abolished slug migration \| delayed aggregation \| decreased number of spores \| decreased aggregate size \| aberrant fruiting body morphology
DBS0236778	pikE-	pikE	wild type
SB16	pirA-	pirA	increased cell motility \| decreased cell size
SB3	pirA-	pirA	increased pseudopod formation \| increased basal F-actin level \| increased cell size \| decreased cell motility
DBS0235411	pkaR-	pkaR	aberrant response to lithium \| aberrant response to valproic acid \| decreased fruiting body size
DBS0236786	pkgB-	pkgB	abolished SDF production \| development arrests at mound stage
DBS0304638	pkgB-	pkgB	decreased cell-substrate adhesion \| development arrests at mound stage \| decreased chemotaxis rate \| increased cell motility
DBS0236787	pkgB-/ [act15]: pkbA	pkbA \| pkgB	wild type
DBS0236789	pkgB-/ [act15]: pkgB(K182M)	pkgB	development arrests at mound stage
DBS0236790	pkgB-/ [gbfA]: pkbA	pkbA \| pkgB	wild type
DBS0236791	pkgB-/ [gbfA]: pkgB	pkgB	wild type
DBS0238068	plaA-	plaA	abolished aggregation
DBS0238067	plaA-	plaA	abolished aggregation
DG1067	plbG-	plbG	decreased stalk width \| decreased stalk length
HAD236	plc-	plc	decreased activation of protein kinase B \| decreased CRAC localization to the plasma membrane \| aberrant chemotaxis to cAMP \| abolished aggregation \| decreased localization of protein to the cytoplasm
HD1.19	plc-	plc	aberrant negative chemotaxis
HD10	plc-	plc	wild type
DBS0267125	plc-/ [OE]: dagA(PH): GFP/ [OE]: plc	dagA \| plc	increased CRAC localization to the plasma membrane \| decreased chemotaxis to cAMP \| aberrant protein localization
DBS0236796	pldB-	pldB	precocious aggregation
DBS0236797	pldB-/ [act15]: pldB: GFP	pldB	abolished aggregation
DBS0236799	plip-	plip	delayed aggregation
DBS0236820	ponA-	ponA	precocious aggregation \| decreased lateral pseudopod traction \| decreased actin nucleation on plasma membranes \| aberrant development
DBS0236821	ponA-	ponA	precocious aggregation \| decreased lateral pseudopod traction \| decreased actin nucleation on plasma membranes \| aberrant development
DG1057	potA-	potA	aberrant fruiting body morphology
DBS0236824	ppk1-	ppk1	decreased phagocytosis \| decreased fruiting body size \| decreased growth rate on bacterial plates \| delayed culmination \| decreased sporulation
DBS0236825	ppk1-/ [act15]: ppk1	ppk1	wild type
DBS0238099	ppp4C-	ppp4c	development arrests at mound stage \| delayed development
DBS0238110	ppp4C-/ [act15]: smkA	ppp4c \| smkA	development arrests at mound stage \| delayed development
DBS0238033	proC-	proC	decreased cell polarity \| increased lateral pseudopod formation \| decreased chemotaxis rate
DBS0238034	proC-/ [unk]: FLAG: proC	proC	wild type
DBS0266716	pscA-	pscA	wild type
HOK2	psiA-	psiA	abolished prespore cell division
DBS0236021	psiM-	psiM	wild type
DBS0236022	psiM-	psiM	wild type
DBS0236828	pslA-	pslA	abolished gene expression \| abolished sporulation \| abolished stalk cell differentiation in vitro \| decreased sorus size \| increased aggregate size \| increased stalk length \| mislocalized gene expression
DBS0236829	psmC1-	psmC1	curly fingers \| increased resistance to spectinomycin \| abolished slug migration \| increased cell size
DBS0302352	psrA-	psrA	decreased culmination \| increased protein phosphorylation \| delayed development \| delayed gene expression \| increased protein kinase activation
DBS0302356	psrA-/ [act15]: FLAG: gskA	gskA \| psrA	increased protein kinase activation
DBS0302353	psrA-/ [act15]: ecmA: lacZ	psrA	aberrant gene expression
DBS0302354	psrA-/ [act15]: ecmB: lacZ	psrA	aberrant gene expression
DBS0302357	psrA-/ [act15]: gskA(K84M/ K85M)	gskA \| psrA	decreased culmination \| decreased gene expression \| delayed development
DBS0302355	psrA-/ [act15]: psrA	psrA	wild type
HM1289	pten-	pten	decreased cell motility
DBS0236830	pten-	pten	abolished CRAC localization to the plasma membrane \| decreased F-actin polymerization \| increased pseudopod formation \| decreased growth rate \| increased F-actin polymerization \| increased lateral pseudopod formation \| decreased cell motility \| increased CRAC localization to the plasma membrane \| decreased chemotaxis to cAMP \| abolished aggregation \| decreased lateral pseudopod suppression
DBS0236831	pten-/ [act15]: GFP: pten-	pten	wild type
DBS0236832	ptpA1-	ptpA1-1	decreased prespore cell differentiation \| precocious development \| increased prestalk O cell differentiation
DBS0236833	ptpB-	ptpB	increased slug size
DBS0236835	pufA-	pufA	precocious development \| aberrant fruiting body morphology
DBS0304391	pyk3-	pyk3	increased gene expression \| decreased gene expression \| increased prespore cell differentiation \| delayed culmination
DBS0304393	pyk3-/ [act15]: T7: pyk3	pyk3	wild type
DBS0236837	pyr56-	pyr56	uracil auxotroph \| increased resistance to 5-fluoroorotic acid (5-FOA)
DBS0236838	pyr56-	pyr56	uracil auxotroph \| increased resistance to 5-fluoroorotic acid (5-FOA)
DBS0236839	qkgA-	qkgA-1 \| qkgA-2	increased aggregate size \| delayed aggregation \| increased growth rate
DBS0236841	racB-	racB	decreased chemoattractant-mediated F-actin polymerization \| delayed aggregation \| decreased basal F-actin level \| decreased chemotaxis rate \| aberrant fruiting body morphology \| decreased myosin II assembly
DBS0236842	racC-	racC	decreased chemotaxis rate \| aberrant cell morphology \| aberrant protein localization
DBS0237191	racC-/ [act15]: CFP: racC	racC	increased chemoattractant-mediated F-actin polymerization
DBS0236843	racF2-	racF2	increased aggregate size \| increased cell-cell adhesion \| decreased sexual fusion
DBS0236849	racG-	racG	decreased cell motility
DBS0236850	racH-	racH	decreased exocytosis \| aberrant protein localization
DBS0266936	rapgap1-	rapgap1	decreased positive regulation of Rap GTPase activity \| increased basal F-actin level \| increased cell-substrate adhesion \| decreased cell motility \| decreased myosin II assembly
DBS0266937	rapgap1-/ [act15]: GFP: rapgap1	rapgap1	decreased cell-substrate adhesion \| increased myosin II assembly \| increased basal F-actin level \| increased lateral pseudopod formation \| increased cell motility \| increased positive regulation of Rap GTPase activity
DBS0236852	rasB-	rasB	decreased growth rate
DBS0236853	rasC-/ AX2	rasC	decreased activation of protein kinase B \| decreased cell motility \| abolished aggregation
DBS0236854	rasC-/ JH10	rasC	decreased activation of protein kinase B \| aberrant gene expression \| abolished aggregation \| abolished chemotaxis to cAMP
DBS0237614	rasC-/ [act15]: gbpD	gbpD \| rasC	increased cell-substrate adhesion \| aberrant cell morphology
DBS0236860	rasD-	rasD	aberrant thermotaxis \| aberrant phototaxis
DBS0236862	rasG-/ AX2	rasG	decreased activation of protein kinase B \| decreased cAMP-induced cGMP pulse \| decreased gene expression \| delayed aggregation \| delayed gene expression
IR15	rasG-/ AX2	rasG	increased cell size \| decreased growth rate
IR17	rasG-/ AX3	rasG	aberrant cytokinesis \| increased cell size \| decreased cell motility
DBS0236863	rasG-/ JH10	rasG	decreased activation of protein kinase B \| decreased cAMP-induced cGMP pulse \| decreased gene expression \| abolished activation of Rap GTPase activity \| delayed aggregation \| delayed gene expression
DBS0236864	rasG-/ [rasG]: rasB	rasB \| rasG	decreased growth rate in suspension
DBS0236872	rasS-	rasS	decreased cell polarity
DBS0236873	rasS-	rasS	decreased growth rate in liquid medium on solid sufaces \| aberrant cytoskeleton organisation \| decreased rate of endocytosis \| increased basal F-actin level \| abolished growth in suspension \| increased cell motility
DBS0236874	rasZ-	rasZ	wild type
DBS0236877	rblA-	rblA	increased sorting to prestalk region \| precocious development \| increased prestalk cell differentiation in response to DIF-1 \| decreased cell size
DBS0236878	rbrA-	rbrA	increased gene expression \| decreased gene expression \| development arrests at slug stage \| mislocalized gene expression \| decreased sorting to prestalk region \| decreased phototaxis \| decreased sporulation
DBS0236879	rbrA-/ [unk]: rbrA	rbrA	wild type
DBS0236880	rckA-	rckA	delayed slug formation \| increased aggregate size \| precocious aggregation \| delayed gene expression \| increased chemotaxis rate
DBS0236885	rckA-/ [act15]: myc: rckA	rckA	delayed development \| decreased chemotaxis rate
DBS0236881	rckA-/ [act15]: myc: rckA(C551A)	rckA	delayed slug formation \| decreased chemotaxis rate
DBS0236882	rckA-/ [act15]: myc: rckA(E510G)	rckA	wild type \| decreased chemotaxis rate
DBS0236883	rckA-/ [act15]: myc: rckA(E510G/ N511A)	rckA	delayed slug formation \| decreased chemotaxis rate
DBS0236884	rckA-/ [act15]: myc: rckA(K867A)	rckA	development arrests at mound stage \| decreased chemotaxis rate
FR17	rdeA-	rdeA	precocious aggregation \| decreased aggregate size \| precocious development \| precocious gene expression \| aberrant fruiting body morphology
FR17	rdeA-	rdeA	precocious aggregation \| decreased aggregate size \| precocious development \| precocious gene expression \| aberrant fruiting body morphology
DBS0236886	rdeA-/ [act15]: rdeA	rdeA	wild type
DBS0236887	recA-	recA	increased sensitivity to mitomycin C (MMC) \| increased sensitivity to UV light \| increased sensitivity to H2O2 (peroxide)
DBS0266664	redA-	redA	development arrests at mound stage \| aberrant mound color
DG1047	redA-	redA	development arrests at mound stage \| aberrant mound color
DBS0236889	regA-	regA	increased resistance to cisplatin \| aberrant chemotaxis to cAMP \| aberrant fruiting body morphology
HM332	regA-	regA	decreased lateral pseudopod suppression
HR45	regA-	regA	aberrant fruiting body morphology
DBS0235706	regA-/ [act15]: dhkK(D1125N)	dhkK \| regA	precocious development \| aberrant fruiting body morphology
DBS0235708	regA-/ [act15]: dhkK(H825Q)	dhkK \| regA	precocious development \| aberrant fruiting body morphology
HM1351	rev3-	rev3	increased sensitivity to cisplatin
HM1451	rev3-/ xpf-	rev3 \| xpf	increased sensitivity to cisplatin
DBS0236893	rgaA-	rgaA	aberrant cytokinesis \| abolished sorting to prestalk region \| abolished stalk cell differentiation \| abolished culmination \| decreased sporulation
DBS0236894	rhgA-	rhgA	wild type
DBS0236902	ripA-/ [unk]: ripA(K680E/ R681E)	ripA	decreased chemotaxis rate \| aberrant development
DBS0236901	ripA-/ [unk]ripA	ripA	wild type
DBS0236903	rnpA-	rnpA	increased gene expression
DBS0238225	rpkA-	rpkA	development arrests at loose aggregate stage \| aberrant response to conditioned medium factor \| decreased cell polarity \| decreased cell motility \| abolished aggregation
DBS0236875	rtoA-	rtoA	decreased rate of endocytosis \| decreased infection rate by Legionella pneumophila \| increased prestalk cell differentiation \| delayed culmination
DBS0236911	rtoA-	rtoA	delayed development
DBS0236914	rzpA-	rzpA	aberrant aggregation \| decreased slug migration \| increased aggregate size \| increased gene expression \| decreased gene expression \| delayed development
DBS0236921	sadA-	sadA	abolished cell-substrate adhesion \| decreased phagocytosis \| aberrant cytokinesis \| aberrant F-actin organization \| increased growth rate \| aberrant cell morphology
DBS0349790	sadA-/ [act15]: sadA(1-923): GFP	sadA	decreased cell-substrate adhesion
DBS0349792	sadA-/ [act15]: sadA(S924A/ S925A): GFP	sadA	wild type
DBS0349791	sadA-/ [act15]: sadA(S924E/ S925E): GFP	sadA	decreased cell-substrate adhesion
DBS0236922	sadA-/ [act15]: sadA: GFP	sadA	wild type
DBS0236924	scrA-	scrA	decreased basal F-actin level \| increased lateral pseudopod formation \| multiple tips \| decreased fruiting body size \| precocious development \| decreased cell size
IR46	scrA-	scrA	decreased cell motility \| decreased cell size
IR48	scrA-	scrA	decreased growth rate \| aberrant cytokinesis
DBS0236925	scrA-	scrA	increased filopodium formation
DBS0237774	scrA-/ [unk]: scrA(97-443): GFP	scrA	aberrant cytoskeleton organisation \| increased cell size \| aberrant cytokinesis \| decreased chemotaxis to cAMP
DBS0237779	scrA-/ [unk]: scrA: GFP	scrA	wild type
DBS0306234	secG-	secG	decreased cell-substrate adhesion \| decreased chemotaxis rate
DBS0236928	set1-	set1	precocious aggregation \| abolished histone H3-K4 methylation \| precocious gene expression
DG1008	sfbA-	sfbA	decreased fruiting body size
SA576	sgkA-	sgkA	increased sensitivity to cisplatin \| increased sensitivity to carboplatin \| decreased growth rate
HM1091	sgkB-	sgkB	increased sensitivity to cisplatin \| increased sensitivity to carboplatin \| decreased growth rate
SA555	sglA-	sglA	aberrant cytoskeleton organisation \| increased stalk width \| increased resistance to cisplatin \| increased aggregate size \| decreased gene expression \| abolished slug migration \| decreased cell motility \| decreased chemotaxis rate \| decreased fruiting body size \| decreased lateral pseudopod suppression \| decreased sporulation
SA554	sglA-	sglA	delayed aggregation \| decreased aggregate size
DBS0236934	shkA-	shkA	aberrant aggregation \| decreased cell polarity \| aberrant F-actin organization \| decreased phagocytosis \| aberrant cytokinesis \| decreased chemotaxis rate \| decreased fruiting body size
DBS0236935	sibA-	sibA	decreased cell-substrate adhesion \| decreased phagocytosis
DBS0302653	sibC-	sibC	decreased phagocytosis
DBS0236936	sigB-	sigB	wild type
DBS0236937	sigD-	sigD	wild type
DBS0236938	smkA-	smkA	aberrant cytokinesis \| delayed development \| decreased chemotaxis rate \| decreased myosin II assembly
HDB7YA	smlA-	smlA	decreased secretion of lysosomal enzyme \| decreased cell-cell adhesion \| decreased cAMP-induced cGMP pulse \| decreased GTP-gamma-S-stimulated guanylyl cyclase activity \| increased cAMP-induced cAMP pulse \| increased resistance to cisplatin \| decreased protein level \| increased basal F-actin level \| increased myosin II assembly \| increased protein level \| increased extracellular counting factor component(s) level \| increased cell motility \| decreased fruiting body size \| increased intracellular counting factor component(s) level
DBS0304496	smlA-/ sslA1(CR11)	smlA \| sslA1	increased fruiting body size
DBS0302523	sodC-	sodC	aberrant cytokinesis
DBS0302524	sodC-	sodC	decreased positive regulation of Ras GTPase activity \| decreased chemoattractant-mediated F-actin polymerization \| aberrant aggregation \| increased localization of protein to the plasma membrane \| aberrant localization of protein to the plasma membrane \| increased basal F-actin level \| decreased chemotaxis rate \| aberrant cell morphology
HL351	spiA-	spiA	decreased spore viability
DBS0236945	splA-	splA	aberrant spore morphology \| increased sorus size \| translucent sorus \| spores inviable \| decreased stalk length
DBS0236947	spnA-	spnA	abolished prespore cell differentiation \| development arrests at mound stage \| abolished prestalk cell differentiation \| aberrant development
DBS0236949	sr-	sr	decreased intracellular pteridine level \| decreased spore viability \| decreased cytochrome C oxidase activity \| decreased growth rate
DBS0236950	srfA(1-8): lacZ	srfA	decreased slug migration \| aberrant fruiting body morphology \| delayed culmination
DBS0236951	srfA-	srfA	aberrant spore morphology \| aberrant spore coat morphology \| decreased spore viability \| decreased gene expression
DBS0266691	srfB-	srfB	aberrant cAMP signaling \| precocious aggregation \| decreased growth rate \| increased pinocytosis \| aberrant cytokinesis \| increased lateral pseudopod formation \| abolished streaming \| precocious gene expression
DBS0304409	srsA-	srsA	decreased gene expression \| increased gene expression \| increased aggregate size \| delayed aggregation
DBS0236952	stkA-	stkA	increased gene expression \| decreased gene expression \| increased prestalk cell differentiation \| aberrant fruiting body morphology \| delayed gene expression
HM1157	stlA-	stlA	wild type
HM1154	stlB-	stlB	abolished prestalk B cell differentation \| abolished DIF production \| decreased prestalk O cell differentiation \| abolished lower cup formation \| abolished outer basal disc formation \| decreased prestalk cell differentiation \| aberrant fruiting body morphology
DBS0304547	svkA-	svkA	delayed cell separation during cytokinesis \| aberrant cytokinesis \| aberrant fruiting body morphology
DBS0236958	t96A	regA	decreased spore germination \| precocious sporulation
AK1200	tagA-	tagA	abolished SDF production \| aberrant fruiting body morphology
AK859	tagA-	tagA	decreased spore viability \| abolished SDF production \| multiple tips in mound \| increased prestalk A cell differentiation
AK1201	tagA-/ [ecmA]: GFP	tagA	abolished sorting to prestalk region
AK228	tagB-	tagB	development arrests at mound stage \| abolished DIF production \| aberrant prestalk A cell differentiation
DBS0236975	tagC-	tagC	development arrests at mound stage \| spores inviable
DBS0236976	talA-	talA	decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased phagocytosis \| aberrant cell morphology
HG1666	talA-	talA	decreased cell-cell adhesion \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased growth rate \| decreased phagocytosis
HG1663	talA-	talA	decreased cell-substrate adhesion
HG1664	talA-	talA	decreased growth rate \| decreased phagocytosis
HG1665	talA-	talA	decreased cell-cell adhesion \| aberrant cytokinesis
DBS0304585	talA-/ [act15]: FLAG: talB	talA \| talB	decreased cell-substrate adhesion
DBS0237616	talA-/ [act15]: gbpD	gbpD \| talA	increased pseudopod formation \| increased cell-substrate adhesion \| aberrant cell morphology
DBS0238395	talA-/ [act15]: rapA(G12V)	rapA \| talA	increased cell-substrate adhesion
DBS0304582	talA-/ talB-/ [act15]: FLAG: talB	talA \| talB	wild type
HKT104	talB-	talB	decreased slug migration \| decreased cell motility \| development arrests at tipped mound stage \| increased protein level
DBS0302472	talB-	talB	abolished autophagic vacuole formation \| abolished autophagic cell death
DBS0304586	talB-/ [act15]: talA: GFP	talA \| talB	aberrant fruiting body morphology
DBS0304820	tgrB1-	tgrB1	development arrests at loose aggregate stage \| delayed sporulation \| decreased sporulation
DBS0304821	tgrC1-	tgrC1	abolished sporulation \| development arrests at loose aggregate stage in the presence of EGTA
AK244	tipA-	tipA	increased aggregate size \| decreased gene expression \| development arrests at mound stage \| multiple tips
JS56	tipB-	tipB	increased aggregate size \| development arrests at mound stage \| multiple tips \| multiple tips in mound
JS55	tipC-	tipC	increased aggregate size \| development arrests at mound stage \| multiple tips
JS93	tipD-	tipD	increased aggregate size \| development arrests at mound stage \| multiple tips
DBS0304519	tirA-	tirA	decreased growth rate \| increased infection rate by Legionella pneumophila
DBS0237017	torA-	torA	delayed aggregation \| decreased growth rate \| decreased cell motility \| decreased chemotaxis rate
DBS0237018	torA-/ [act15]: torA: GFP	torA	abolished growth
DBS0237924	triA-	triA	decreased cell-cell adhesion \| aberrant streaming \| increased stalk width \| aberrant upper cup formation \| decreased spore viability \| aberrant culminant morphology \| decreased spore size \| decreased cell fate determination \| increased number of aggregates \| decreased cell fate commitment
DBS0237996	triA-	triA	aberrant culminant morphology
DBS0237997	triA-	triA	aberrant culminant morphology
DBS0237998	triA-/ [act15]: GFP	triA	aberrant culminant morphology
DBS0237999	triA-/ [ecmAO]: lacZ: [ecmAO]: gus	triA	increased prestalk O cell differentiation
DBS0238001	triA-/ [psA]: lacZ: [psA]: gus	triA	increased prespore cell differentiation
DBS0237022	tsg101-	tsg101	decreased fruiting body size
DBS0302370	tsuA-	tsuA	increased period of cAMP wave formation \| aberrant chemotaxis to folate \| aberrant chemotaxis to cAMP \| delayed aggregation \| decreased aggregate size \| abolished cell polarity \| decreased fruiting body size
DBS0302383	tsuA-/ [unk]: tsuA(1-1774): YFP	tsuA	abolished localization of protein to the microtubule organizing center \| decreased aggregate size \| abolished localization of protein to microtubules \| decreased fruiting body size
DBS0302385	tsuA-/ [unk]: tsuA(1-260): YFP	tsuA	abolished localization of protein to the microtubule organizing center \| abolished localization of protein to microtubules \| decreased aggregate size \| decreased fruiting body size
DBS0302384	tsuA-/ [unk]: tsuA(1774-2247): YFP	tsuA	abolished localization of protein to the microtubule organizing center \| abolished localization of protein to microtubules \| decreased aggregate size \| decreased fruiting body size
DBS0302382	tsuA-/ [unk]: tsuA(K34R): YFP	tsuA	decreased aggregate size \| decreased fruiting body size
DBS0302381	tsuA-/ [unk]: tsuA: YFP	tsuA	wild type
DBS0237024	ubcB-	ubcB	development arrests at mound stage \| multiple tips
DBS0306165	ube2t-	ube2t	increased sensitivity to cisplatin
DBS0237025	ubpA-	ubpA	decreased gene expression \| decreased chemotaxis rate \| abolished aggregation \| decreased cAMP-induced cAMP pulse
DBS0237026	ubpB-	ubpB	aberrant sorus morphology \| increased gene expression \| decreased gene expression \| precocious development
DBS0237027	ufc1-	ufc1	wild type
DBS0266763	ugpB-/ DH1	ugpB	decreased stalk length
DBS0266764	ugpB-/ HMX	ugpB	abolished cellulose biosynthesis \| decreased autophagic vacuole formation \| aberrant cell morphology
DBS0237031	vacA-	vacA	wild type
DBS0237032	vacB-	vacB	decreased exocytosis
DBS0237034	vasP-	vasP	abolished filopodium formation
DBS0237035	vasP-	vasP	decreased cell-substrate adhesion \| aberrant F-actin organization \| decreased chemotaxis rate \| decreased lateral pseudopod suppression \| decreased cell size \| abolished filopodium formation \| decreased filopodium formation
DBS0237033	vasP-/ [act15]: GFP: vasP(1-264/ 285-380)	vasP	abolished filopodium formation
DBS0237836	vasP-/ [act15]: YFP: wipA	vasP \| wipA	decreased filopodium formation
DBS0237842	vasP-/ [act15]: YFP: wipA/ [act15]: vasP: FLAG	vasP \| wipA	increased filopodium formation
DBS0237036	vasP-/ [act15]: myr: vasP	vasP	increased filopodium formation \| increased basal F-actin level \| aberrant cytokinesis
DBS0237040	vasP-/ [act15]: vasP	vasP	decreased filopodium formation
DBS0237840	vasP-/ [act15]: vasP	vasP	increased filopodium formation \| increased basal F-actin level
DBS0237037	vasP-/ [act15]: vasP(1-110: 231-380)	vasP	increased basal F-actin level \| aberrant cytokinesis \| decreased filopodium formation
DBS0237038	vasP-/ [act15]: vasP(1-228)	vasP	decreased filopodium formation
DBS0237039	vasP-/ [act15]: vasP(111-380)	vasP	increased filopodium formation \| increased basal F-actin level
DBS0236058	vmp1-	vmp1	aberrant aggregation \| decreased exocytosis \| decreased pinocytosis \| aberrant response to hypo-osmotic stress \| decreased gene expression \| decreased growth rate
DG1118	vps46-	vps46	increased sorus size
DBS0237046	vwkA-	vwkA	decreased growth rate in suspension \| increased myosin II assembly \| aberrant cytokinesis \| delayed development \| increased protein level \| aberrant fruiting body morphology
TL61	wacA-	wacA	wild type
TL99	wacA-	wacA	wild type
DBS0237048	warA-	warA	development arrests at slug stage \| increased basal disc size \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DBS0237049	warA-	warA	development arrests at slug stage \| increased basal disc size \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DG1053	wimA-	wimA	aberrant fruiting body morphology
DG1064	wimA-	wimA	aberrant fruiting body morphology
HM1458	xpc-	xpc	wild type
HM1403	xpf-	xpf	increased sensitivity to cisplatin \| decreased double-strand break repair via homologous recombination
AK235	yakA-	yakA	abolished aggregation
AK800	yakA-	yakA	abolished aggregation
DBS0237091	yakA-/ [crlA]: crlA	crlA \| yakA	abolished growth
DG1014	yelA-	yelA	decreased spore viability \| precocious sporulation \| development arrests at mound stage \| aberrant mound color
DBS0349797	zak2-	zak2	decreased gene expression \| decreased protein kinase activation \| decreased sporulation \| aberrant fruiting body morphology
DBS0349798	zak2-/ [ecmA]: LacZ	zak2	aberrant gene expression
ARK100-110	zakA-	zakA	decreased glycogen synthase kinase 3 activity \| increased gene expression \| decreased gene expression \| abolished streaming \| decreased chemotaxis to cAMP \| delayed culmination \| aberrant fruiting body morphology \| decreased sporulation
DBS0238142	zakA-	zakA	development arrests at tipped mound stage
DBS0349803	zakA-/ [ecmB]: LacZ	zakA	aberrant gene expression
DG1050	zipA-	zipA	decreased fruiting body size

Last updated January 28, 2012


		Genomes Dictyostelium discoideum Dictyostelium purpureum Explore Learn About Dicty Dictyostelium Genome Resources D. discoideum Genome Statistics Pictures/Videos dictyArt Useful Links Virtual Library Dictyostelium Page Research Techniques Teaching Protocols Dicty Anatomy Ontology Mutant Phenotypes HTP Phenotyping at Princeton Codon Bias Table Nomenclature Guidelines Axenic Strains History Franke Dictyostelium Reference Library Tools Genome Browser Chromosome 1 Chromosome 2 Chromosome 3 Chromosome 4 Chromosome 5 Chromosome 6 Mitochondrial DNA Ribosomal DNA RNAseq Browser (beta) Chromosome 1 Chromosome 2 Chromosome 3 Chromosome 4 Chromosome 5 Chromosome 6 Mitochondrial DNA Ribosomal DNA BLAST ID Converter dictyMart Textpresso Biochemical Pathways Third Party Tools Stock Center Dicty Stock Center Home About Stock Center Search Stock Center Order Deposit Strain Catalog Plasmid Catalog Bacterial strain Catalog Additional Materials Nomenclature Guidelines Other Stock Centers Download Community Submit an Abstract to dictyNews Read the dictyNews ListServ Archive Add or update your colleague profile Dicty Annual Conference Job opportunities Dicty Labs on the Web Citing dictyBase and the Dictyostelium Genome Project		About Us Contact Help